|
US5187193A
(en)
*
|
1988-09-12 |
1993-02-16 |
University Of Rochester |
Method for stimulating transplanted bone marrow cells
|
|
WO1991005571A1
(en)
*
|
1989-10-10 |
1991-05-02 |
University Of Rochester |
Method for producing bone marrow growth cell factors
|
|
JPH06509578A
(ja)
*
|
1991-07-26 |
1994-10-27 |
ユニバーシティ・オブ・ロチェスター |
悪性細胞利用による癌治療法
|
|
US5240914A
(en)
*
|
1992-02-03 |
1993-08-31 |
Adolph Schwimmer |
Method and compositions for inhibiting tumor cell metabolism
|
|
US6514949B1
(en)
|
1994-07-11 |
2003-02-04 |
University Of Virginia Patent Foundation |
Method compositions for treating the inflammatory response
|
|
US6448235B1
(en)
|
1994-07-11 |
2002-09-10 |
University Of Virginia Patent Foundation |
Method for treating restenosis with A2A adenosine receptor agonists
|
|
US7135584B2
(en)
*
|
1995-08-07 |
2006-11-14 |
Wake Forest University |
Lipid analogs for treating viral infections
|
|
EP0781138B1
(de)
*
|
1994-08-29 |
2008-05-21 |
Wake Forest University |
Lipid-analoge zur behandlung von viralen infektionen
|
|
US5767142A
(en)
*
|
1996-03-20 |
1998-06-16 |
Rutgers, The State University Of New Jersey |
Trisbenzimidazoles useful as topoisomerase I inhibitors
|
|
US5807874A
(en)
*
|
1995-05-17 |
1998-09-15 |
Rutgers, The State University Of New Jersey |
Trisbenzimidazoles useful as topoisomerase I inhibitors
|
|
US5616575A
(en)
*
|
1995-12-04 |
1997-04-01 |
Regents Of The University Of Minnesota |
Bioactive tricyclic ibogaine analogs
|
|
US5932553A
(en)
*
|
1996-07-18 |
1999-08-03 |
The Regents Of The University Of California |
Illudin analogs useful as antitumor agents
|
|
US5723632A
(en)
|
1996-08-08 |
1998-03-03 |
Mgi Pharma, Inc. |
Total synthesis of antitumor acylfulvenes
|
|
US5922761A
(en)
*
|
1996-09-06 |
1999-07-13 |
Medinox, Inc. |
Methods for in vivo reduction of iron levels and compositions useful therefor
|
|
JP2001501197A
(ja)
*
|
1996-09-23 |
2001-01-30 |
ルトガーズ，ザ ステイト ユニバーシティ オブ ニュージャージー |
抗―腫瘍剤としての置換された複素環式化合物類
|
|
US5916903A
(en)
*
|
1997-02-28 |
1999-06-29 |
Synapse Pahrmaceuticals International, Inc. |
Method for reducing the effects of antineoplastic disease treatment
|
|
US5866558A
(en)
*
|
1997-05-08 |
1999-02-02 |
Regents Of The University Of Minnesota |
6-alkynyl steroids
|
|
US6468519B1
(en)
*
|
1997-09-10 |
2002-10-22 |
Rutgers, The State University Of New Jersey |
Polyanhydrides with biologically active degradation products
|
|
US6486214B1
(en)
|
1997-09-10 |
2002-11-26 |
Rutgers, The State University Of New Jersey |
Polyanhydride linkers for production of drug polymers and drug polymer compositions produced thereby
|
|
US6140328A
(en)
*
|
1997-12-12 |
2000-10-31 |
Rutgers, The State University Of New Jersey |
Heterocyclic cytotoxic agents
|
|
JP3866298B2
(ja)
*
|
1997-12-29 |
2007-01-10 |
リサーチ コーポレイション テクノロジーズ，インコーポレイティド |
β−ラクタマーゼインヒビターとしての２β−置換化−６−アルキリデンペニシラン酸誘導体
|
|
US6432941B1
(en)
*
|
1998-01-20 |
2002-08-13 |
Parker Hughes Institute |
Vanadium compounds for treating cancer
|
|
US6245808B1
(en)
|
1998-11-05 |
2001-06-12 |
Parker Hughes Institute |
Oxy-vanadium (IV) complexes having spermicidal activity
|
|
US6051603A
(en)
|
1998-01-20 |
2000-04-18 |
Wayne Hughes Institute |
Vanadium (IV) metallocene complexes having sperm motility inhibiting activity
|
|
US6063801A
(en)
*
|
1998-02-12 |
2000-05-16 |
Rutgers, The State University Of New Jersey |
Heterocyclic topoisomerase poisons
|
|
US6025328A
(en)
|
1998-02-20 |
2000-02-15 |
The Regents Of The University Of California |
Antitumor agents
|
|
US7141603B2
(en)
*
|
1999-02-19 |
2006-11-28 |
The Regents Of The University California |
Antitumor agents
|
|
US6117878A
(en)
*
|
1998-02-24 |
2000-09-12 |
University Of Virginia |
8-phenyl- or 8-cycloalkyl xanthine antagonists of A2B human adenosine receptors
|
|
US6355678B1
(en)
*
|
1998-06-29 |
2002-03-12 |
Parker Hughes Institute |
Inhibitors of the EGF-receptor tyrosine kinase and methods for their use
|
|
US6800649B1
(en)
|
1998-06-30 |
2004-10-05 |
Parker Hughes Institute |
Method for inhibiting c-jun expression using JAK-3 inhibitors
|
|
US6323190B1
(en)
|
1998-07-31 |
2001-11-27 |
The Univeristy Of Georgia Research Foundation, Inc. |
Estrogen mimetics lacking reproductive tract effects
|
|
US6232297B1
(en)
*
|
1999-02-01 |
2001-05-15 |
University Of Virginia Patent Foundation |
Methods and compositions for treating inflammatory response
|
|
US7378400B2
(en)
*
|
1999-02-01 |
2008-05-27 |
University Of Virginia Patent Foundation |
Method to reduce an inflammatory response from arthritis
|
|
US7427606B2
(en)
*
|
1999-02-01 |
2008-09-23 |
University Of Virginia Patent Foundation |
Method to reduce inflammatory response in transplanted tissue
|
|
US6166003A
(en)
*
|
1999-02-17 |
2000-12-26 |
Lkt Laboratories, Inc. |
Heterocyclic compounds for cancer chemoprevention
|
|
AU3239400A
(en)
|
1999-02-22 |
2000-09-04 |
University Of Iowa Research Foundation, The |
Method for inhibiting inflammatory responses
|
|
US6080747A
(en)
*
|
1999-03-05 |
2000-06-27 |
Hughes Institute |
JAK-3 inhibitors for treating allergic disorders
|
|
ATE226208T1
(de)
|
1999-03-09 |
2002-11-15 |
Upjohn Co |
4-oxo-4,7-dihydro-thieno(2,3-b)pyridin-5- carboxamide als antivirale mittel
|
|
US6258820B1
(en)
*
|
1999-03-19 |
2001-07-10 |
Parker Hughes Institute |
Synthesis and anti-tumor activity of 6,7-dialkoxy-4-phenylamino-quinazolines
|
|
US6306897B1
(en)
|
1999-03-19 |
2001-10-23 |
Parker Hughes Institute |
Calanolides for inhibiting BTK
|
|
US7064114B2
(en)
*
|
1999-03-19 |
2006-06-20 |
Parker Hughes Institute |
Gel-microemulsion formulations
|
|
US6407091B1
(en)
*
|
1999-04-15 |
2002-06-18 |
Research Corporation Technologies, Inc. |
β-lactamase inhibiting compounds
|
|
US6930101B1
(en)
|
1999-05-17 |
2005-08-16 |
The Regents Of The University Of California |
Thiazolopyrimidines useful as TNFα inhibitors
|
|
US6322771B1
(en)
|
1999-06-18 |
2001-11-27 |
University Of Virginia Patent Foundation |
Induction of pharmacological stress with adenosine receptor agonists
|
|
AU5630800A
(en)
|
1999-06-22 |
2001-01-09 |
Arno F Spatola |
Antimicrobial agents
|
|
US6946458B2
(en)
|
1999-07-22 |
2005-09-20 |
University Of South Florida |
N-thiolated beta-lactams: novel antibacterial agents for methicillin-resistant Staphylococcus aureus
|
|
US7151100B1
(en)
*
|
1999-07-23 |
2006-12-19 |
The Regents Of The University Of California |
Indole compounds useful for the treatment of cancer
|
|
US6852685B1
(en)
|
1999-08-17 |
2005-02-08 |
Board Of Regents, The University Of Texas System |
Use of colostrinin, constituent peptides thereof, and analogs thereof to promote neuronal cell differentiation
|
|
US6903068B1
(en)
|
1999-08-17 |
2005-06-07 |
Board Of Regents, The University Of Texas System |
Use of colostrinin, constituent peptides thereof, and analogs thereof for inducing cytokines
|
|
EP1218018A4
(de)
|
1999-08-17 |
2005-06-01 |
Univ Texas |
Verwendung von colostrinin, seine peptidbestandteile und ihre analogen als regulatoren bei oxidativem stress
|
|
US7119064B2
(en)
*
|
1999-08-17 |
2006-10-10 |
Board Of Regents, The University Of Texas System |
Use of colostrinin, constituent peptides thereof, and analogs thereof as modulators of intracellular signaling molecules
|
|
MY125942A
(en)
|
1999-09-07 |
2006-09-29 |
Upjohn Co |
Aminoalkoxy carbazoles for the treatment of cns diseases
|
|
US6670341B1
(en)
|
1999-10-28 |
2003-12-30 |
Wake Forest University Health Sciences |
Compositions and methods for double-targeting virus infections and targeting cancer cells
|
|
US7026469B2
(en)
*
|
2000-10-19 |
2006-04-11 |
Wake Forest University School Of Medicine |
Compositions and methods of double-targeting virus infections and cancer cells
|
|
US6740650B2
(en)
|
1999-10-29 |
2004-05-25 |
Rutgers, The State University Of New Jersey |
Heterocyclic cytotoxic agents
|
|
WO2001036431A1
(en)
|
1999-11-15 |
2001-05-25 |
Parker Hughes Institute |
Diamino platinum (ii) antitumor complexes
|
|
US6649654B1
(en)
|
1999-11-23 |
2003-11-18 |
The Regents Of The University Of California |
Methods for identifying and using IKK inhibitors
|
|
US6589992B2
(en)
|
1999-11-30 |
2003-07-08 |
Parker Hughes Institute |
Inhibiting collagen-induced platelet aggregation
|
|
US6685928B2
(en)
|
1999-12-07 |
2004-02-03 |
Rutgers, The State University Of New Jersey |
Therapeutic compositions and methods
|
|
US20040038948A1
(en)
|
1999-12-07 |
2004-02-26 |
Uhrich Kathryn E. |
Therapeutic compositions and methods
|
|
AU2001231016A1
(en)
*
|
2000-01-20 |
2001-07-31 |
Regents Of The University Of Minnesota |
Peptides with antibacterial activity
|
|
CN1416430A
(zh)
|
2000-03-21 |
2003-05-07 |
法玛西雅厄普约翰美国公司 |
作为抗病毒药的4－氧－1,4－二氢[1,8]－二氮杂萘－3－甲酰胺类
|
|
CA2399741A1
(en)
|
2000-03-21 |
2001-11-01 |
Scott D. Larsen |
4-hydroxycinnoline-3-carboxyamides as antiviral agents
|
|
BR0108845A
(pt)
|
2000-03-21 |
2003-05-06 |
Upjohn Co |
4-hidroxi-1,8-naftiridina-3-carboxamidas como agentes antivirais
|
|
US6682892B2
(en)
|
2000-07-13 |
2004-01-27 |
Pharmacia & Upjohn Company |
Method for treating herpes viruses
|
|
US20040152672A1
(en)
*
|
2000-08-09 |
2004-08-05 |
Carson Dennis A. |
Indole compounds useful for the treatment of cancer
|
|
US6696441B1
(en)
|
2000-08-11 |
2004-02-24 |
The Regents Of The University Of California |
Inhibition of p53-induced stress response
|
|
AU2001294953A1
(en)
|
2000-09-29 |
2002-04-08 |
Regents Of The University Of Minnesota |
Triterpenes having fungicidal activity against yeast
|
|
US6951847B2
(en)
*
|
2000-09-29 |
2005-10-04 |
Regents Of The University Of Minnesota |
Methods of treating fungal infections using lupeol
|
|
AU2001294959A1
(en)
|
2000-09-29 |
2002-04-08 |
Robert M. Carlson |
Triterpenes having antibacterial activity
|
|
US7309696B2
(en)
|
2000-10-19 |
2007-12-18 |
Wake Forest University |
Compositions and methods for targeting cancer cells
|
|
US6958359B1
(en)
|
2000-11-15 |
2005-10-25 |
Parker Hughes Institute |
Vanadium compounds as anti-angiogenic agents
|
|
US6878388B1
(en)
|
2000-11-15 |
2005-04-12 |
Parker Hughes Institute |
Vanadium compounds for treating proliferative cell disorders
|
|
US6642221B1
(en)
|
2000-11-15 |
2003-11-04 |
Parker Hughes Institute |
Vanadium compounds as anti-proliferative agents
|
|
AU2002249885A1
(en)
|
2000-11-17 |
2002-08-12 |
Adolor Corporation |
Delta agonist analgesics
|
|
US20040034045A1
(en)
*
|
2000-11-29 |
2004-02-19 |
Parker Hughes Institute |
Inhibitors of thrombin induced platelet aggregation
|
|
WO2002060936A2
(en)
*
|
2001-01-31 |
2002-08-08 |
University Of Iowa Research Foundation |
Vaccine and compositions for the prevention and treatment of neisserial infections
|
|
US7261901B2
(en)
*
|
2001-01-31 |
2007-08-28 |
University Of Iowa Research Foundation |
Vaccine and compositions for the prevention and treatment of neisserial infections
|
|
US6703524B2
(en)
|
2001-02-20 |
2004-03-09 |
Lkt Laboratories, Inc. |
Organoselenium compounds for cancer chemoprevention
|
|
US7232829B2
(en)
*
|
2001-04-06 |
2007-06-19 |
Regents Of The University Of Minnesota |
Therapeutic compounds and methods
|
|
GB0111872D0
(en)
*
|
2001-05-15 |
2001-07-04 |
Northwick Park Inst For Medica |
Therapeutic agents and methods
|
|
EP1397326A2
(de)
*
|
2001-05-29 |
2004-03-17 |
Koninklijke Philips Electronics N.V. |
Metall-keramik verbund
|
|
US7601846B2
(en)
*
|
2001-06-26 |
2009-10-13 |
The Regents Of The University Of California |
Compounds having activity as inhibitors of apoptosis
|
|
US20030232794A1
(en)
*
|
2001-06-26 |
2003-12-18 |
Cottam Howard B. |
Use of STAT-6 inhibitors as therapeutic agents
|
|
ES2272795T3
(es)
*
|
2001-07-24 |
2007-05-01 |
Southern Methodist University Foundation For Research |
7-alquildieno-3-sustituidos-3-cefem-4-carboxilatos como inhibidores de beta-lactamasa.
|
|
US6753414B2
(en)
*
|
2001-08-07 |
2004-06-22 |
University Of Iowa Research Foundation, Inc. |
Process for preparing saponin compounds
|
|
MXPA04001203A
(es)
|
2001-08-08 |
2004-05-20 |
Pharmacia & Upjhon Company |
1-h-pirido[4,3-b] indoles terapeuticos.
|
|
US20030171377A1
(en)
*
|
2001-08-29 |
2003-09-11 |
Bigge Christopher Franklin |
Antidiabetic agents
|
|
WO2003020728A1
(en)
|
2001-08-30 |
2003-03-13 |
Pharmacia & Upjohn Company |
4-THIOXO-4,7-DIHYDRO-THIENO[2,3-b]PYRIDINE-5-CARBOTHIOAMIDES AS ANTIVIRAL AGENTS
|
|
KR100871648B1
(ko)
*
|
2001-08-31 |
2008-12-03 |
톰슨 라이센싱 |
조건부 액세스 시스템을 구현하는 방법, 컨텐트를 전송하는 방법 및 그 장치 및 컨텐트를 수신하고 처리하는 방법 및 그 장치
|
|
MXPA04002615A
(es)
*
|
2001-09-21 |
2004-07-08 |
Upjohn Co |
Compuestos del ligando 5-ht terapeuticos.
|
|
EP1430017A2
(de)
|
2001-09-26 |
2004-06-23 |
Theravance, Inc. |
Substituierter phenolverbindungen zur anästhesie und sedierung
|
|
WO2003029264A2
(en)
*
|
2001-10-01 |
2003-04-10 |
University Of Virginia Patent Foundation |
2-propynyl adenosine analogs having a2a agonist activity and compositions thereof
|
|
US20030143199A1
(en)
*
|
2001-10-09 |
2003-07-31 |
Carson Dennis A. |
Use of STAT-6 inhibitors as therapeutic agents
|
|
US7399743B2
(en)
*
|
2001-10-26 |
2008-07-15 |
The Scripps Research Institute |
Targeted thrombosis
|
|
WO2003041660A2
(en)
|
2001-11-14 |
2003-05-22 |
Rutgers, The State University |
Solubilized topoisomerase poisons
|
|
DE60228484D1
(de)
|
2001-11-14 |
2008-10-02 |
Univ Rutgers |
Cytotoxische mittel
|
|
ES2323771T3
(es)
|
2001-11-23 |
2009-07-24 |
Rutgers, The State University |
Sintesis mejorada de polianhidridos.
|
|
US7030141B2
(en)
|
2001-11-29 |
2006-04-18 |
Christopher Franklin Bigge |
Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
|
|
AU2003205332A1
(en)
*
|
2002-01-25 |
2003-09-02 |
Philip S. Portoghese |
Selective analgesic agents
|
|
US7968605B2
(en)
*
|
2002-02-04 |
2011-06-28 |
ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. |
Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
|
|
US20080026984A1
(en)
*
|
2002-02-04 |
2008-01-31 |
Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda |
Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
|
|
EP2319518A1
(de)
*
|
2002-02-04 |
2011-05-11 |
ALFAMA-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda. |
Verwendung CO-freisetzender Verbindungen zur Behandlung entzündlicher Erkrankungen
|
|
CA2475187A1
(en)
|
2002-02-07 |
2003-08-14 |
Rutgers, The State University Of New Jersey |
Therapeutic polyesters and polyamides
|
|
AU2003216400A1
(en)
|
2002-02-22 |
2003-09-09 |
The Curators Of The University Of Missouri |
Compounds for treatment of copper overload
|
|
US20050032713A1
(en)
*
|
2002-03-27 |
2005-02-10 |
Wurtman Richard J. |
Platelet-activating factor antagonists as analgesic, anti-inflammatory, uterine contraction inhibiting, and anti-tumor agents
|
|
JP2005525399A
(ja)
*
|
2002-04-04 |
2005-08-25 |
アラムクス エルエルシー |
セリンおよびメタロ−β−ラクタマーゼの阻害剤
|
|
WO2003090682A2
(en)
*
|
2002-04-25 |
2003-11-06 |
The Scripps Research Institute |
Treatment and prevention of pulmonary conditions
|
|
US7026472B2
(en)
*
|
2002-05-06 |
2006-04-11 |
University Of South Florida |
Methods for preventing and treating cancer using N-thiolated β-lactam compounds and analogs thereof
|
|
US20040156799A1
(en)
*
|
2002-06-04 |
2004-08-12 |
Zigang Dong |
Cancer treatment method and compositions
|
|
UA79293C2
(en)
*
|
2002-07-03 |
2007-06-11 |
Univ Wayne State |
4-(7'-halo-2-quino (xa-) linyloxy)phenoxy propionic acid derivatives as antineoplastic agents
|
|
WO2004004640A2
(en)
*
|
2002-07-05 |
2004-01-15 |
Tetragrammaton Inc. |
Methods, compositions and kits for treating damage to excitable tissue
|
|
US6989387B2
(en)
*
|
2002-08-09 |
2006-01-24 |
Rutgers, The State University Of New Jersey |
Nitro and amino substituted topoisomerase agents
|
|
BR0314219A
(pt)
*
|
2002-09-11 |
2005-07-19 |
Warner Lambert Co |
Inibidores do fator xa e outras serina proteases envolvidas na cascata da coagulação
|
|
WO2004026116A2
(en)
*
|
2002-09-19 |
2004-04-01 |
The Regents Of The University Of California |
Use of etodoclac to treat hyperplasia
|
|
EP1565080B1
(de)
|
2002-10-10 |
2014-01-15 |
Cornell Research Foundation, Inc. |
Neue immunogene proteine von leptospira
|
|
AU2003301353A1
(en)
*
|
2002-10-18 |
2004-05-04 |
Cylene Pharmaceuticals |
Processes for identifying quadruplex-targeted antiviral molecules
|
|
US20050042300A1
(en)
*
|
2002-10-22 |
2005-02-24 |
Istvan Boldogh |
Use of colostrinin, constituent peptides thereof, and analogs thereof as inhibitors of apoptosis and other cellular damage
|
|
DE60305727T2
(de)
*
|
2002-10-28 |
2007-05-31 |
Paraquest, Inc., Bloomington |
Hypoestoxide, derivate und agonisten davon zur verwendung bei der behandlung und prophylaxe von hyperlipidämie
|
|
JP2006520584A
(ja)
|
2002-11-08 |
2006-09-14 |
アブリンクス エン．ヴェー． |
安定化単一ドメイン抗体
|
|
AU2003286003B2
(en)
|
2002-11-08 |
2011-05-26 |
Ablynx N.V. |
Stabilized single domain antibodies
|
|
GB2395432B
(en)
*
|
2002-11-20 |
2005-09-14 |
Northwick Park Inst For Medica |
Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
|
|
AU2003295954A1
(en)
*
|
2002-11-26 |
2004-06-18 |
Gilead Sciences, Inc. |
Method of drug loading in liposomes by gradient
|
|
AU2003296944A1
(en)
*
|
2002-12-10 |
2004-06-30 |
George Koob |
A method for treatment of drug addiction and for screening of pharmaceutical agents therefor
|
|
WO2007062048A2
(en)
|
2005-11-21 |
2007-05-31 |
Scripps Research Inst |
Role of proteoglycans in drug dependence
|
|
WO2004062583A2
(en)
*
|
2003-01-07 |
2004-07-29 |
University Of Iowa Research Foundation |
Vaccine and method for preventing biofilm formation
|
|
MXPA05006043A
(es)
|
2003-01-10 |
2006-01-30 |
Ablynx Nv |
Polipeptidos terapeuticos, homologos de los mismos, fragmentos de los mismos y para uso al modular la agregacion mediada de plaquetas.
|
|
US20050079512A1
(en)
*
|
2003-02-26 |
2005-04-14 |
Emerson Beverly M. |
Methods of modulating gene expression
|
|
WO2004087672A1
(en)
|
2003-03-28 |
2004-10-14 |
Cornell Research Foundation, Inc. |
Migrastatin analog compositions and uses thereof
|
|
US7163948B2
(en)
*
|
2003-04-07 |
2007-01-16 |
Cylene Pharmaceuticals, Inc. |
Heterocyclic substituted 1,4-dihydri-4ox9-1,8-naphthyridine analogs
|
|
US7507727B2
(en)
*
|
2003-04-07 |
2009-03-24 |
Cylene Pharmaceuticals, Inc. |
Substituted quinobenzoxazine analogs and methods of using thereof
|
|
MXPA05010776A
(es)
*
|
2003-04-07 |
2006-05-25 |
Cylene Pharmaceuticals Inc |
Analogos sustituidos de quinobenzoxazina.
|
|
US7354916B2
(en)
*
|
2003-04-07 |
2008-04-08 |
Cylene Pharmaceuticals |
Substituted quinobenzoxazine analogs
|
|
US20040248880A1
(en)
*
|
2003-04-25 |
2004-12-09 |
Jacobsen Eric Jon |
1,2,3,4,5,6-Hexahydroazepino[4,5-B]indoles containing arylsulfones at the 9-position
|
|
CA2536357A1
(en)
*
|
2003-05-29 |
2004-12-23 |
The Scripps Research Institute |
Targeted delivery to legumain-expressing cells
|
|
US7812058B2
(en)
|
2003-06-25 |
2010-10-12 |
The Burnham Institute |
Methods and compounds useful to induce apoptosis in cancer cells
|
|
WO2005003140A1
(en)
*
|
2003-07-02 |
2005-01-13 |
Pharmacia & Upjohn Company Llc |
4-oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxamides as antiviral agents
|
|
NZ545715A
(en)
|
2003-08-25 |
2009-02-28 |
Adenosine Therapeutics Llc |
Substituted 8-heteroaryl xanthines
|
|
US7850970B2
(en)
|
2003-08-26 |
2010-12-14 |
The Regents Of The University Of Colorado |
Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections
|
|
US9532994B2
(en)
|
2003-08-29 |
2017-01-03 |
The Regents Of The University Of California |
Agents and methods for enhancing bone formation by oxysterols in combination with bone morphogenic proteins
|
|
AU2004285122A1
(en)
*
|
2003-10-17 |
2005-05-12 |
Regents Of The University Of Minnesota |
Modified polypeptides with therapeutic activity and methods of use
|
|
AU2003283136A1
(en)
|
2003-11-07 |
2005-05-26 |
Ablynx N.V. |
Camelidae single domain antibodies vhh directed against epidermal growth factor receptor and uses therefor
|
|
WO2005055994A1
(en)
*
|
2003-12-04 |
2005-06-23 |
The Scripps Research Institute |
Treatment and preventions of asthma
|
|
NZ548209A
(en)
*
|
2003-12-19 |
2009-07-31 |
Univ California |
Methods and materials for assessing prostate cancer thearapies
|
|
NZ548195A
(en)
|
2004-01-14 |
2011-01-28 |
Gilead Sciences Inc |
Lipid-based dispersions useful for drug delivery
|
|
US7491701B2
(en)
*
|
2004-01-27 |
2009-02-17 |
Boys Town National Research Hospital |
Peptides that bind to HSP90 proteins
|
|
US8841326B2
(en)
|
2004-02-12 |
2014-09-23 |
Stc.Unm |
Therapeutic curcumin derivatives
|
|
US20050187191A1
(en)
*
|
2004-02-20 |
2005-08-25 |
Kucera Louis S. |
Methods and compositions for the treatment of respiratory syncytial virus
|
|
US20050187192A1
(en)
*
|
2004-02-20 |
2005-08-25 |
Kucera Pharmaceutical Company |
Phospholipids for the treatment of infection by togaviruses, herpes viruses and coronaviruses
|
|
WO2005099693A2
(en)
*
|
2004-02-24 |
2005-10-27 |
The Regents Of The University Of California |
Methods and materials for assessing prostate cancer therapies and compounds
|
|
LT2574341T
(lt)
|
2004-03-29 |
2017-09-11 |
University Of South Florida |
Navikų ir vėžio efektyvus gydymas triciribino fosfatu
|
|
WO2006001967A2
(en)
*
|
2004-05-25 |
2006-01-05 |
Sloan-Kettering Institute For Cancer Research |
Migrastatin analogs in the treatment of cancer
|
|
NZ553288A
(en)
*
|
2004-08-02 |
2010-12-24 |
Univ Virginia |
2-propynyl adenosine analogs with modified 5'-ribose groups having A2A agonist activity
|
|
US7576069B2
(en)
*
|
2004-08-02 |
2009-08-18 |
University Of Virginia Patent Foundation |
2-polycyclic propynyl adenosine analogs having A2A agonist activity
|
|
WO2006023272A1
(en)
*
|
2004-08-02 |
2006-03-02 |
University Of Virginia Patent Foundation |
2-polycyclic propynyl adenosine analogs having a2a agonist activity
|
|
WO2006026380A2
(en)
*
|
2004-08-25 |
2006-03-09 |
University Of Iowa Research Foundation |
Geranylgeranyl pyrophosphate synthase inhibitors
|
|
WO2006031857A2
(en)
*
|
2004-09-13 |
2006-03-23 |
Gilead Sciences, Inc. |
Delivering iron to an animal
|
|
US7718680B2
(en)
*
|
2004-09-23 |
2010-05-18 |
Burnham Institute For Medical Research |
Inhibition of lethal factor protease activity from anthrax toxin
|
|
EP1805161B1
(de)
*
|
2004-09-23 |
2014-05-07 |
Sloan-Kettering Institute For Cancer Research |
Isomigrastatinanaloga bei der krebsbehandlung
|
|
CA2583017A1
(en)
*
|
2004-10-13 |
2006-04-20 |
Ablynx N.V. |
Single domain camelide anti-amyloid beta antibodies and polypeptides comprising the same for the treatment and diagnosis of degenerative neural diseases such as alzheimer's disease
|
|
US8697674B2
(en)
|
2004-12-29 |
2014-04-15 |
Naturon, Inc. |
Xanthurenic acid derivative pharmaceutical compositions and methods related thereto
|
|
CA2594542C
(en)
*
|
2005-01-10 |
2014-03-25 |
University Of Virginia Patent Foundation |
Synthesis of inhibitors of p90rsk
|
|
US7691364B2
(en)
*
|
2005-01-28 |
2010-04-06 |
Bezwada Biomedical, Llc |
Functionalized drugs and polymers derived therefrom
|
|
US7709517B2
(en)
*
|
2005-05-13 |
2010-05-04 |
The Regents Of The University Of California |
Diarylhydantoin compounds
|
|
KR20230003445A
(ko)
|
2005-05-13 |
2023-01-05 |
더 리전트 오브 더 유니버시티 오브 캘리포니아 |
디아릴히단토인 화합물
|
|
PL1888641T3
(pl)
|
2005-05-18 |
2012-05-31 |
Ablynx Nv |
Białka wiążące albuminę surowicy
|
|
HUE039846T2
(hu)
|
2005-05-20 |
2019-02-28 |
Ablynx Nv |
Javított nanotestek (TM) aggregáció közvetítette rendellenességek kezelésére
|
|
US20070025910A1
(en)
|
2005-07-29 |
2007-02-01 |
Norenberg Jeffrey P |
Anticancer therapy
|
|
WO2007019308A2
(en)
*
|
2005-08-03 |
2007-02-15 |
The Regents Of The University Of California |
Illudin analogs useful as anticancer agents
|
|
ES2577514T3
(es)
|
2005-08-22 |
2016-07-15 |
The Regents Of The University Of California |
Antagonistas de TLR
|
|
US8871764B2
(en)
|
2005-08-29 |
2014-10-28 |
University Of Virginia Patent Foundation |
Lisofylline analogs and methods for use
|
|
DK1919867T3
(da)
|
2005-08-29 |
2011-12-12 |
Univ Virginia Patent Found |
Lisofyllinanaloger og farmaceutiske anvendelser heraf
|
|
WO2007053794A2
(en)
|
2005-10-21 |
2007-05-10 |
Bezwada Biomedical Llc |
Functionalized phenolic compounds and absorbable therefrom
|
|
WO2007056113A2
(en)
*
|
2005-11-02 |
2007-05-18 |
Cylene Pharmaceuticals, Inc. |
Methods for targeting quadruplex sequences
|
|
CN101374856A
(zh)
*
|
2005-11-29 |
2009-02-25 |
斯克里普斯研究学院 |
抑制肿瘤细胞浸润、转移和血管生成
|
|
US8007526B2
(en)
|
2005-12-01 |
2011-08-30 |
Bezwada Biomedical, Llc |
Difunctionalized aromatic compounds and polymers therefrom
|
|
US20070161546A1
(en)
*
|
2005-12-15 |
2007-07-12 |
Colm King |
Methods and compositions for treatment of cancer
|
|
WO2007073226A1
(en)
*
|
2005-12-20 |
2007-06-28 |
Alfama - Investigação E Desenvolvimento De Produtos Farmacêuticos Lda |
Method for treating a mammal by administration of a compound having the ability to release co
|
|
US20070244057A1
(en)
*
|
2006-01-20 |
2007-10-18 |
Henry Paulson |
Suppressing polyglutamine aggregation and toxicity
|
|
GB0601394D0
(en)
|
2006-01-24 |
2006-03-01 |
Hemocorm Ltd |
Therapeutic delivery of carbon monoxide
|
|
US7615649B2
(en)
*
|
2006-01-26 |
2009-11-10 |
Iowa State University Research Foundation, Inc, |
Synthesis of polycyclic procyanidins
|
|
WO2007120972A2
(en)
*
|
2006-02-10 |
2007-10-25 |
University Of Virginia Patent Foundation |
Method to treat sickle cell disease
|
|
WO2007098139A2
(en)
*
|
2006-02-21 |
2007-08-30 |
The Ohio State University Research Foundation |
Anticancer agents
|
|
JP2009528291A
(ja)
|
2006-02-27 |
2009-08-06 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
オキシステロール化合物及びヘッジホッグ経路
|
|
US7919626B2
(en)
|
2006-02-28 |
2011-04-05 |
Helicon Therapeutics, Inc. |
Pyrazole compounds and uses thereof
|
|
US8093274B2
(en)
*
|
2006-03-22 |
2012-01-10 |
The Regents Of The University Of California |
Inhibitors of protein prenyltransferases
|
|
EP2368550B1
(de)
|
2006-03-27 |
2013-09-04 |
The Regents of the University of California |
Androgenrezeptor-Modulator zur Behandlung von Prostatakrebs und androgenrezeptor-assoziierte Erkrankungen
|
|
SG170809A1
(en)
*
|
2006-03-29 |
2011-05-30 |
Univ California |
Diarylthiohydantoin compounds
|
|
US8093235B2
(en)
|
2006-04-25 |
2012-01-10 |
Rutgers, The State University Of New Jersey |
Macrocyclic compounds which stabilize G-Quadruplex DNA and RNA
|
|
WO2007139778A2
(en)
*
|
2006-05-22 |
2007-12-06 |
University Of Virginia Patent Foundation |
Rhamnose substituents of sl0101 and therapeutic uses thereof
|
|
EP2700638A1
(de)
|
2006-05-31 |
2014-02-26 |
The Regents Of the University of California |
Purinanaloga
|
|
EP2046315B1
(de)
*
|
2006-06-02 |
2013-04-10 |
The Ohio State University Research Foundation |
Therapeutische mittel zur behandlung des mantelzell-lymphoms
|
|
WO2007146831A2
(en)
*
|
2006-06-08 |
2007-12-21 |
Cylene Pharmaceuticals, Inc. |
Quinolone analogs derivatized with sulfonic acid, sulfonate or sulfonamide
|
|
WO2007146813A2
(en)
*
|
2006-06-08 |
2007-12-21 |
Cylene Pharmaceuticals, Inc. |
Pyridinone analogs as cell proliferation inhibitors
|
|
CN101466382A
(zh)
|
2006-06-16 |
2009-06-24 |
PGx健康有限责任公司 |
取代的8-[6-氨基-3-吡啶基]黄嘌呤
|
|
US8188063B2
(en)
*
|
2006-06-19 |
2012-05-29 |
University Of Virginia Patent Foundation |
Use of adenosine A2A modulators to treat spinal cord injury
|
|
WO2008034019A2
(en)
|
2006-09-13 |
2008-03-20 |
Polymerix Corporation |
Active agents and their oligomers and polymers
|
|
WO2008036244A1
(en)
*
|
2006-09-18 |
2008-03-27 |
The Burham Institute For Medical Research |
Use of cyclosporin a to sensitize resistant cancer cells to death receptor ligands
|
|
EP2086318A4
(de)
*
|
2006-10-10 |
2009-12-23 |
Burnham Inst Medical Research |
Neuroprotektive zusammensetzungen und verfahren
|
|
US8034829B2
(en)
|
2006-11-17 |
2011-10-11 |
Rexahn Pharmaceuticals, Inc. |
5, 6, or 7-substituted-3-(hetero)arylisoquinolinamine derivatives and therapeutic use thereof
|
|
EP2086962A1
(de)
*
|
2006-11-29 |
2009-08-12 |
Pfizer Products Inc. |
(r)-5-methyl-4,5-dihydropyrazol-1,5-dicarbonsäure-1-[(4-chlorphenyl)amid-5-{[2-fluor-4-(2-oxo-2h-pyridin-1-yl)phenyl]amid) als faktor-xa-inhibitor
|
|
EP2102244A2
(de)
|
2006-12-19 |
2009-09-23 |
Ablynx N.V. |
Gegen metalloproteinase aus der adam-familie gerichtete aminosäuresequenzen und diese enthaltende polypeptide zur behandlung von mit adam in zusammenhang stehenden krankheiten und störungen
|
|
CA2673331A1
(en)
|
2006-12-19 |
2008-06-26 |
Ablynx N.V. |
Amino acid sequences directed against gpcrs and polypeptides comprising the same for the treatment of gpcr-related diseases and disorders
|
|
US8207381B2
(en)
|
2007-02-06 |
2012-06-26 |
University Of Louisville Research Foundation |
Therapeutic compounds
|
|
WO2008115319A2
(en)
|
2007-02-07 |
2008-09-25 |
Regents Of The University Of California |
Conjugates of synthetic tlr agonists and uses therefor
|
|
WO2008103818A1
(en)
*
|
2007-02-21 |
2008-08-28 |
University Of Louisville Research Foundation |
Therapeutic cotinine compositions
|
|
CA2679301C
(en)
|
2007-02-28 |
2015-08-11 |
University Of Virginia Patent Foundation |
Lisofylline analogs and methods for use in protecting pancreatic .beta.-cells, treating type 1 diabetes, and treating inflammatory and autoimmune diseases
|
|
US8569449B2
(en)
|
2007-05-08 |
2013-10-29 |
University Of Louisville Research Foundation, Inc. |
Synthetic peptides and peptide mimetics
|
|
JP5568471B2
(ja)
*
|
2007-07-12 |
2014-08-06 |
ユニヴァーシティ オブ サウス フロリダ |
抗腫瘍活性を有するａｋｔ／ｐｋｂの阻害剤
|
|
MX2010001303A
(es)
|
2007-08-02 |
2010-09-07 |
Univ Rutgers |
Compuestos terapeuticos.
|
|
US20090087497A1
(en)
*
|
2007-08-16 |
2009-04-02 |
Burnham Institute For Medical Research |
Compositions and methods for treating symptoms of aging
|
|
ES2663517T3
(es)
|
2007-08-27 |
2018-04-13 |
Dart Neuroscience (Cayman) Ltd |
Compuestos terapéuticos de isoxazol
|
|
US8217134B2
(en)
|
2007-08-30 |
2012-07-10 |
Bezwada Biomedical, Llc |
Controlled release of biologically active compounds
|
|
US8048980B2
(en)
|
2007-09-17 |
2011-11-01 |
Bezwada Biomedical, Llc |
Hydrolysable linkers and cross-linkers for absorbable polymers
|
|
JP5824213B2
(ja)
|
2007-10-05 |
2015-11-25 |
センワ バイオサイエンシズ インコーポレイテッド |
キノロン類似体およびそれに関連する方法
|
|
JP2011502963A
(ja)
|
2007-10-19 |
2011-01-27 |
バーンハム インスティテュート フォー メディカル リサーチ |
抗アポトーシスタンパク質であるナフタレン系阻害剤
|
|
WO2009055677A1
(en)
*
|
2007-10-24 |
2009-04-30 |
University Of South Florida |
Antibacterial s-heterosubstituted disulfides
|
|
TW201716385A
(zh)
|
2007-10-26 |
2017-05-16 |
加州大學董事會 |
二芳基乙內醯脲類化合物
|
|
WO2009059030A1
(en)
*
|
2007-10-31 |
2009-05-07 |
Burnham Institute For Medical Research |
Pyrazole derivatives as kinase inhibitors
|
|
CA2707663C
(en)
|
2007-12-03 |
2017-05-30 |
The Regents Of The University Of California |
Oxysterols for activation of hedgehog signaling, osteoinduction, antiadipogenesis, and wnt signaling
|
|
US8058259B2
(en)
*
|
2007-12-20 |
2011-11-15 |
University Of Virginia Patent Foundation |
Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists
|
|
EA201001264A1
(ru)
*
|
2008-02-07 |
2011-04-29 |
Дзе Регентс Оф Дзе Юниверсити Оф Калифорния |
Способ лечения заболеваний мочевого пузыря с помощью активатора tlr7
|
|
US8142764B2
(en)
|
2008-02-27 |
2012-03-27 |
University Of Louisville Research Foundation |
Synthetic biofilm-inhibiting peptides
|
|
WO2009114539A2
(en)
*
|
2008-03-10 |
2009-09-17 |
University Of Louisville Research Foundation |
Neuroprotective integrin-binding peptide and angiopoietin-1 treatments
|
|
US20110046101A1
(en)
*
|
2008-03-17 |
2011-02-24 |
Dmitrienko Gary I |
Bate-lactamase inhibitors
|
|
WO2009146112A1
(en)
*
|
2008-04-02 |
2009-12-03 |
University Of Virginia Patent Foundation |
Compositions and methods for inhibiting sphingosine kinase
|
|
AU2009235467A1
(en)
|
2008-04-07 |
2009-10-15 |
Ablynx Nv |
Single variable domains against the Notch pathways
|
|
BRPI0911984A2
(pt)
|
2008-05-16 |
2016-09-20 |
Ablynx Nv |
sequências de aminoácidos direncionadas contra cxcr4 e outros compostos gpcrs compreendendo os mesmos
|
|
US9872867B2
(en)
*
|
2008-06-06 |
2018-01-23 |
Tanya Kuritz |
Methods and compositions for modulation of innate immunity
|
|
EP2299809B1
(de)
|
2008-06-17 |
2018-10-17 |
Ben Gurion University Of The Negev R&D Authority |
Substituierte cyclohexyliden-ethyliden-octahydroinden-verbindungen
|
|
WO2010005534A2
(en)
*
|
2008-06-30 |
2010-01-14 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Proteasome inhibitors for selectively inducing apoptosis in cancer cells
|
|
US7947717B2
(en)
*
|
2008-07-18 |
2011-05-24 |
Burnham Institute For Medical Research |
Inhibitors of lethal factor protease
|
|
US9125821B2
(en)
|
2008-07-28 |
2015-09-08 |
The Regents Of The University Of California |
Nanodrug targeting protein geranylgeranylation
|
|
US20110178138A1
(en)
*
|
2008-07-28 |
2011-07-21 |
The Regents Of The University Of California |
Inhibitors of protein prenyltransferases
|
|
EP2320934A4
(de)
*
|
2008-08-05 |
2012-08-01 |
Univ South Florida |
Verfahren zur behandlung von kognitiver beeinträchtigung
|
|
US9132168B2
(en)
|
2008-08-05 |
2015-09-15 |
University Of South Florida |
Methods of treating cognitive impairment
|
|
US8871983B2
(en)
*
|
2008-08-08 |
2014-10-28 |
University Of Florida Research Foundation, Inc. |
Lipid compounds for suppression of tumorigenesis
|
|
US9801865B2
(en)
|
2008-09-24 |
2017-10-31 |
The United States Of America As Represented By The Department Of Veteran Affairs |
Materials and methods for diagnosis, prevention and/or treatment of stress disorders and conditions associated with abeta peptide aggregation
|
|
US8124654B2
(en)
*
|
2008-11-11 |
2012-02-28 |
Immune Modulation, Inc. |
Derivatives of hypoestoxide and related compounds
|
|
TW201038578A
(en)
|
2009-01-30 |
2010-11-01 |
Univ Rutgers |
Methods to treat cancer
|
|
WO2010088924A1
(en)
|
2009-02-06 |
2010-08-12 |
Telormedix Sa |
Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
|
|
US8729088B2
(en)
|
2009-02-11 |
2014-05-20 |
The Regents Of The University Of California |
Toll-like receptor modulators and treatment of diseases
|
|
JP5773888B2
(ja)
|
2009-03-06 |
2015-09-02 |
ラットガーズ，ザ・ステート・ユニバーシティ・オブ・ニュージャージー |
癌治療に用いられるメチレンジオキシベンゾ［ｉ］フェナントリジン誘導体
|
|
CN102438619A
(zh)
|
2009-03-20 |
2012-05-02 |
衣阿华大学研究基金会 |
作为抗结核剂的异戊二烯化双膦酸盐
|
|
EP3461844A3
(de)
|
2009-04-10 |
2019-05-15 |
Ablynx N.V. |
Verbesserte, gegen il-6r gerichtete aminosäuresequenzen und polypeptide damit zur behandlung von erkrankungen und störungen im zusammenhang mit il-6r
|
|
EA201101326A1
(ru)
|
2009-04-15 |
2012-05-30 |
Сэнфорд-Бёрнхэм Медикал Рисёч Инститьют |
Ингибиторы антиапоптотических белков на основе нафталина
|
|
US8487131B2
(en)
|
2009-04-15 |
2013-07-16 |
Sanford-Burnham Medical Research Institute |
Optically pure apogossypol derivative as pan-active inhibitor of anti-apoptotic B-cell lymphoma/leukemia-2 (BCL-2)
|
|
US20120108823A1
(en)
|
2009-04-22 |
2012-05-03 |
The Ohio State University Research Foundation |
Anti-francisella agents
|
|
WO2010132504A1
(en)
|
2009-05-11 |
2010-11-18 |
University Of Tennessee Research Foundation |
Anti-inflammatory quinic acid derivatives for radioprotection/radiomitigation
|
|
US8748618B2
(en)
|
2009-05-13 |
2014-06-10 |
University Of Virginia Patent Foundation |
Inhibitors of inv(16) leukemia
|
|
EP2448953A1
(de)
|
2009-06-30 |
2012-05-09 |
Forest Laboratories Holdings Limited |
Alkoxy-carbonyl-amino-alkynyl-adenosinverbindungen und derivate daraus als a2ar-agonisten
|
|
WO2011005871A1
(en)
|
2009-07-07 |
2011-01-13 |
Pgxhealth, Llc |
Substituted 8-[6-carbonylamine-3-pyridyl]xanthines as adenosine a2b antagonists
|
|
WO2011004166A1
(en)
|
2009-07-09 |
2011-01-13 |
Cbt Development Limited |
Combined preparation for use as a medicament
|
|
EP2459562A1
(de)
|
2009-07-31 |
2012-06-06 |
Biocryst Pharmaceuticals, Inc. |
Pyrrolo[1,2-b]pyridinderivate als januskinasehemmer
|
|
WO2011019995A2
(en)
|
2009-08-14 |
2011-02-17 |
Hecht Sidney M |
Synthesis and identification of novel rsk-specific inhibitors
|
|
TW201111385A
(en)
|
2009-08-27 |
2011-04-01 |
Biocryst Pharm Inc |
Heterocyclic compounds as janus kinase inhibitors
|
|
US8993535B2
(en)
|
2009-09-04 |
2015-03-31 |
Merck Sharp & Dohme Corp. |
Modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors
|
|
US8642088B2
(en)
|
2009-09-04 |
2014-02-04 |
Wisconsin Alumni Research Foundation |
Tannin-chitosan composites
|
|
EA201270347A1
(ru)
*
|
2009-10-08 |
2012-11-30 |
Санфорд-Бернхам Медикал Ресерч Инститъют |
Производные апогоссиполона в качестве противоопухолевых агентов
|
|
WO2011057126A1
(en)
|
2009-11-05 |
2011-05-12 |
Rutgers, The State University Of New Jersey |
Therapeutic compounds
|
|
KR20120092175A
(ko)
|
2009-12-04 |
2012-08-20 |
죤 이. 그랜트 |
카테콜-0-메틸-트랜스퍼라제 저해제를 사용한 충동 제어 장애의 치료
|
|
US20120309773A1
(en)
|
2009-12-23 |
2012-12-06 |
Babu Yarlagadda S |
Heterocyclic compounds as janus kinase inhibitors
|
|
EP2516396A1
(de)
|
2009-12-23 |
2012-10-31 |
Wayne State University |
Therapeutische verbindungen
|
|
EP2536708A4
(de)
|
2010-02-16 |
2013-05-29 |
Aragon Pharmaceuticals Inc |
Androgenrezeptormodulatoren und ihre verwendung
|
|
US20120329770A1
(en)
|
2010-02-26 |
2012-12-27 |
Gary Igor Dmitrienko |
Cephalosporin derivatives useful as beta-lactamase inhibitors and compositions and methods of use thereof
|
|
EP2552969A1
(de)
|
2010-03-29 |
2013-02-06 |
SurModics, Inc. |
Injizierbare wirkstofffreisetzungsformulierung
|
|
CN103108861A
(zh)
|
2010-04-02 |
2013-05-15 |
Tsrl公司 |
神经氨酸酶抑制剂
|
|
US20130130965A1
(en)
|
2010-04-08 |
2013-05-23 |
University Of Virginia Patent Foundation |
Method to detect and treat infectious or inflammatory diarrhea based on reg1
|
|
WO2011130740A2
(en)
|
2010-04-16 |
2011-10-20 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Pyridylthiazole-based ureas as inhibitors of rho associated protein kinase (rock) and methods of use
|
|
WO2011133696A2
(en)
|
2010-04-20 |
2011-10-27 |
Regents Of The University Of Minnesota |
Methods of suppressing atherosclerosis
|
|
BR112012029994A2
(pt)
|
2010-05-28 |
2019-09-24 |
Biocryst Pharm Inc |
composto heterocíclicos como inibidores de janus quinase
|
|
CA2810162A1
(en)
|
2010-06-09 |
2011-12-15 |
Rutgers, The State University Of New Jersey |
Antimicrobial agents
|
|
US9102617B2
(en)
|
2010-06-25 |
2015-08-11 |
Rutgers, The State University Of New Jersey |
Antimicrobial agents
|
|
US8741317B2
(en)
|
2010-08-19 |
2014-06-03 |
Rutgers, The State University Of New Jersey |
Slow-degrading polymers comprising salicylic acid for undelayed and sustained drug delivery
|
|
WO2012027494A1
(en)
|
2010-08-24 |
2012-03-01 |
Regents Of The University Of Minnesota |
Bispecific targeting reagents
|
|
US20120083473A1
(en)
|
2010-09-21 |
2012-04-05 |
Johanna Holldack |
Treatment of conditions by toll-like receptor modulators
|
|
AU2011323784A1
(en)
|
2010-10-25 |
2013-05-30 |
Regents Of The University Of Minnesota |
Therapeutic composition for treatment of glioblastoma
|
|
WO2012058665A1
(en)
|
2010-10-29 |
2012-05-03 |
University Of Connecticut |
Compositions and methods for modulation and detection of immune and inflammatory responses
|
|
EP3363435A1
(de)
|
2010-11-01 |
2018-08-22 |
The Ohio State University Research Foundation |
Celecoxibderivate gegen staphylokokken
|
|
AU2011326034B2
(en)
|
2010-11-12 |
2016-02-04 |
Roche Innovation Center Copenhagen A/S |
Compositions and methods for treating androgen receptor dependent disorders including cancers
|
|
US8309768B2
(en)
|
2010-11-29 |
2012-11-13 |
The Ohio State University Research Foundation |
FTY720-derived anticancer agents
|
|
WO2012087889A2
(en)
|
2010-12-20 |
2012-06-28 |
The Ohio State University Research Foundation |
Dna methylation inhibitors
|
|
US8933119B2
(en)
|
2011-01-03 |
2015-01-13 |
The William M. Yarbrough Foundation |
Method for treating phytophotodermatitis
|
|
US10308599B2
(en)
|
2011-01-03 |
2019-06-04 |
The William M. Yarbrough Foundation |
Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
|
|
US11279674B2
(en)
|
2011-01-03 |
2022-03-22 |
The William M. Yarbrough Foundation |
Isothiocyanate functional surfactant and associated method of use
|
|
US10640464B2
(en)
|
2011-01-03 |
2020-05-05 |
The William M. Yarbrough Foundation |
Use of isothiocyanate functional surfactants as Nrf2 inducers to treat epidermolysis bullosa simplex and related diseases
|
|
US10273205B2
(en)
|
2011-01-03 |
2019-04-30 |
The William M. Yarbrough Foundation |
Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms
|
|
US9962361B2
(en)
|
2011-01-03 |
2018-05-08 |
The William M. Yarbrough Foundation |
Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
|
|
US11407713B2
(en)
|
2011-01-03 |
2022-08-09 |
The William M. Yarbrough Foundation |
Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
|
|
US10647668B2
(en)
|
2011-01-03 |
2020-05-12 |
The William M. Yarbrough Foundation |
Isothiocyanate functional surfactant and associated method of use
|
|
US8865765B2
(en)
|
2011-01-12 |
2014-10-21 |
The William M. Yarbrough Foundation |
Method for treating eczema
|
|
EP3660010B1
(de)
|
2011-02-07 |
2022-07-27 |
Biogen MA Inc. |
S1p-modulierende mittel
|
|
US9532969B2
(en)
|
2011-02-08 |
2017-01-03 |
The William M. Yarbrough Foundation |
Method for treating psoriasis
|
|
US9383364B2
(en)
|
2011-03-07 |
2016-07-05 |
University Of Louisville Research Foundation, Inc. |
Predictive marker of DNMT1 inhibitor therapeutic efficacy and methods of using the marker
|
|
US9616064B2
(en)
|
2011-03-30 |
2017-04-11 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Rho kinase inhibitors and methods of use
|
|
MX356426B
(es)
|
2011-04-04 |
2018-05-29 |
Univ Iowa Res Found |
Metodos para mejorar inmunogenicidad de vacuna.
|
|
US20140030341A1
(en)
|
2011-04-06 |
2014-01-30 |
Rutgers, The State University Of New Jersey |
Polymers and methods for the treatment of pain
|
|
JP5978291B2
(ja)
|
2011-04-19 |
2016-08-24 |
アルファーマ インコーポレイテッドＡｌｆａｍａ，Ｉｎｃ． |
一酸化炭素放出分子およびその使用
|
|
WO2012145678A1
(en)
|
2011-04-20 |
2012-10-26 |
Regents Of The University Of Minnesota |
Anti-cancer and anti-inflammatory parthenolide compounds
|
|
US9415112B2
(en)
|
2011-06-20 |
2016-08-16 |
Rutgers, The State University Of New Jersey |
Bipartite inhibitors of bacterial RNA polymerase
|
|
US9133230B2
(en)
|
2011-06-21 |
2015-09-15 |
The United States Of America As Represented By The Department Of Veterans Affairs |
Hydrazone derivatives having potent antitumor activity toward multi-drug resistant tumor cells
|
|
US9394338B2
(en)
|
2011-07-08 |
2016-07-19 |
Regents Of The University Of Minnesota |
Glutathione analogs and uses thereof
|
|
WO2013013179A1
(en)
|
2011-07-21 |
2013-01-24 |
Alfama, Inc. |
Ruthenium carbon monoxide releasing molecules and uses thereof
|
|
EP2734519B1
(de)
|
2011-07-22 |
2016-05-04 |
University Of Louisville Research Foundation, Inc. |
Anti-biofilm verbindungen
|
|
EA028452B1
(ru)
|
2011-07-29 |
2017-11-30 |
Медивейшн Простейт Терапьютикс, Инк. |
Лечение рака молочной железы
|
|
US20150017091A1
(en)
|
2011-08-18 |
2015-01-15 |
Cornell University |
Detection and treatment of metastatic disease
|
|
WO2013028866A1
(en)
|
2011-08-24 |
2013-02-28 |
Regents Of The University Of Minnesota |
Therapeutic compounds and methods
|
|
EP2750508A4
(de)
|
2011-08-30 |
2015-01-14 |
Univ Wayne State |
Therapeutische verbindungen und verfahren
|
|
US9034336B2
(en)
|
2011-08-30 |
2015-05-19 |
Regents Of The University Of Minnesota |
Immunomodulators and immunomodulator conjugates
|
|
US9808425B2
(en)
|
2011-09-08 |
2017-11-07 |
Western University Of Health Sciences |
Targeted liposomes in cancer therapy
|
|
EP2910549A1
(de)
|
2011-09-15 |
2015-08-26 |
Arizona Board of Regents, a Body Corporate of the State of Arizona acting for and on behalf of Arizona State University |
1,2,3,4-tetrahydro-1,1,4,4-tetramethylnaphthalenderivate als rxr-modulatoren zur behandlung von alzheimer-krankheit und krebs
|
|
PL2773325T3
(pl)
|
2011-11-04 |
2019-03-29 |
Enceladus Pharmaceuticals B.V. |
Liposomalne kortykosteroidy w leczeniu chorób zapalnych u istot ludzkich
|
|
US9828326B2
(en)
*
|
2011-12-27 |
2017-11-28 |
Northeast Ohio Medical University |
Amooranin compounds and analogs thereof and related methods of use
|
|
WO2013103969A1
(en)
|
2012-01-05 |
2013-07-11 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: phloroglucinol derivatives
|
|
US9512212B2
(en)
|
2012-01-11 |
2016-12-06 |
Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University |
Bispecific antibody fragments for neurological disease proteins and methods of use
|
|
WO2013106756A2
(en)
|
2012-01-13 |
2013-07-18 |
Rutgers, The State University Of New Jersey |
Antimicrobial agents
|
|
EP3269372B1
(de)
|
2012-01-19 |
2019-06-12 |
Hybrid Medical, LLC |
Topische therapeutische formulierungen
|
|
US9296728B2
(en)
|
2012-01-20 |
2016-03-29 |
Regents Of The University Of Minnesota |
Therapeutic compounds
|
|
WO2013111528A1
(ja)
*
|
2012-01-25 |
2013-08-01 |
Ｓｂｉファーマ株式会社 |
腫瘍診断剤
|
|
US20130195752A1
(en)
|
2012-02-01 |
2013-08-01 |
Regents Of The University Of Minnesota |
Functionalized nanoparticles and methods of use thereof
|
|
CA2863427C
(en)
|
2012-02-01 |
2022-07-12 |
The Governors Of The University Of Alberta |
Use of pdgfr-.alpha. as diagnostic marker for papillary thyroid cancer
|
|
WO2013119564A1
(en)
|
2012-02-06 |
2013-08-15 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: combination of a rifamycin and a switch region inhibitor
|
|
EP2822548B1
(de)
|
2012-02-08 |
2019-04-24 |
University of Virginia Patent Foundation |
Langkettige sphingosin-kinasehemmer
|
|
CN104487059B
(zh)
|
2012-03-02 |
2017-06-23 |
伊利诺伊大学评议会 |
由双重化合物激活的强有效的抗癌活性
|
|
ES2646008T3
(es)
|
2012-03-06 |
2017-12-11 |
The Board Of Trustees Of The University Of Illinois |
Terapia combinada de procaspasa para el tratamiento del cáncer
|
|
US9475783B2
(en)
|
2012-03-21 |
2016-10-25 |
Rutgers, The State University Of New Jersey |
Antimicrobial agents
|
|
US9187446B2
(en)
|
2012-03-22 |
2015-11-17 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: sidechainfluorinated myxopyronin derivatives
|
|
CA2868508A1
(en)
|
2012-03-26 |
2013-10-03 |
University Of Iowa Research Foundation |
Schweinfurthin analogues
|
|
US9272016B2
(en)
|
2012-04-20 |
2016-03-01 |
University Of Iowa Research Foundation |
Methods to enhance RNAi oligonucleotide delivery to respiratory epithelial cells
|
|
EP2847206A4
(de)
|
2012-05-07 |
2016-01-20 |
Univ California |
Oxysterol-analogon oxy133 zur induktion von osteogenese und hedgehog-signalisierung sowie zur adipogenesehemmung
|
|
EP2852390A1
(de)
|
2012-05-21 |
2015-04-01 |
Chemi Nutra Inc. |
Zusammensetzungen und verfahren zur erhöhung der festigkeit und muskelmasse
|
|
WO2013177458A1
(en)
|
2012-05-23 |
2013-11-28 |
Chemi Nutra |
Compositions for increasing strength, muscle mass, and lean body mass
|
|
US20130323221A1
(en)
|
2012-05-30 |
2013-12-05 |
Biostrategies LC |
Plant lectins as carriers of associated drug substances into animal and human cells
|
|
WO2013188882A1
(en)
|
2012-06-15 |
2013-12-19 |
Rutgers, The State University Of New Jersey |
Macromolecules for treating atherosclerosis
|
|
CN104583217B
(zh)
|
2012-06-18 |
2017-11-17 |
达特神经科学(开曼)有限公司 |
取代的噻吩稠合的和呋喃稠合的唑并嘧啶‑5‑(6h)‑酮化合物
|
|
EP2861570B1
(de)
|
2012-06-19 |
2018-07-18 |
Rutgers, The State University of New Jersey |
Antibakterielle wirkstoffe: arylmyxopyroninderivate
|
|
US9492448B2
(en)
|
2012-06-20 |
2016-11-15 |
University Of Virginia Patent Foundation |
Compositions and methods for regulating glucose homeostasis and insulin action
|
|
JP6226974B2
(ja)
|
2012-07-05 |
2017-11-08 |
ユニバーシティー オブ アイオワ リサーチ ファウンデーション |
治療用ビスホスホネート
|
|
EP2872525B1
(de)
|
2012-07-10 |
2019-03-06 |
XPD Holdings LLC |
Stabilisierte multifunktionale antioxidative verbindungen und verfahren zur verwendung
|
|
CN104718213B
(zh)
|
2012-07-18 |
2018-02-27 |
圣母大学 |
5,5‑杂芳族抗感染化合物
|
|
WO2014018671A1
(en)
|
2012-07-24 |
2014-01-30 |
Regents Of The University Of Minnesota |
Therapeutic compounds for the treatment of cancer
|
|
WO2014018874A1
(en)
|
2012-07-26 |
2014-01-30 |
The William M. Yarbrough Foundation |
Method for treating skin cancer
|
|
US10434082B2
(en)
|
2012-07-26 |
2019-10-08 |
The William M. Yarbrough Foundation |
Isothiocyanate functional compounds augmented with secondary antineoplastic medicaments and associated methods for treating neoplasms
|
|
US9949943B2
(en)
|
2012-07-26 |
2018-04-24 |
The William M. Yarbrough Foundation |
Method for treating neurodegenerative diseases
|
|
US10080734B2
(en)
|
2012-07-26 |
2018-09-25 |
The William M. Yarbrough Foundation |
Method for treating autism and other neurodevelopmental disorders
|
|
US10434081B2
(en)
|
2012-07-26 |
2019-10-08 |
The William M. Yarbrough Foundation |
Inhibitors of macrophage migration inhibitory factor
|
|
US10441561B2
(en)
|
2012-07-26 |
2019-10-15 |
The William M. Yanbrough Foundation |
Method for treating benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer
|
|
US9839621B2
(en)
|
2012-07-26 |
2017-12-12 |
The William M. Yarbrough Foundation |
Method for treating bladder cancer
|
|
US10335387B2
(en)
|
2012-07-26 |
2019-07-02 |
The William M. Yarbrough Foundation |
Method for treating infectious diseases with isothiocyanate functional compounds
|
|
AU2013295584B2
(en)
|
2012-07-27 |
2018-03-15 |
Biogen Ma Inc. |
ATX modulating agents
|
|
KR20150036767A
(ko)
|
2012-08-01 |
2015-04-07 |
루이스 앤드 클라크 파마슈티컬스, 인코포레이티드 |
A2a 효능제로서의 n-알킬 2-(이치환된)알키닐아데노신-5-유론아미드
|
|
US9249116B2
(en)
|
2012-08-03 |
2016-02-02 |
The Board Of Trustees Of The University Of Illinois |
Enzyme-activating compounds and compositions
|
|
EP2879673B1
(de)
|
2012-08-06 |
2018-07-25 |
Biogen MA Inc. |
1,5,6-substituierte Naphthalin-Derivate als Sphingosine 1 Phosphat (S1P) Rezeptor und/oder Autotaxin (ATX) Modulatoren zur Behandlung von Entzündungen und Autoimmunerkrankungen
|
|
US10273234B2
(en)
|
2012-08-06 |
2019-04-30 |
Biogen Ma Inc. |
Compounds that are S1P modulating agents and/or ATX modulating agents
|
|
WO2014028025A1
(en)
|
2012-08-16 |
2014-02-20 |
University Of Southern California |
Compositions and methods for treating myotonic dystrophy type 1
|
|
JP6371284B2
(ja)
|
2012-08-22 |
2018-08-08 |
コーネル ユニヴァーシティー |
ファスシンを阻害する方法
|
|
US9737493B2
(en)
|
2012-09-07 |
2017-08-22 |
University Of Louisville Research Foundation, Inc. |
Compositions and methods for modulating DNMT1 inhibitor activity
|
|
WO2014043252A2
(en)
|
2012-09-11 |
2014-03-20 |
Rutgers, The State University Of New Jersey |
Therapeutic hydroxypyridinones, hydroxypyrimidinones and hydroxypyridazinones
|
|
EP2895202A1
(de)
|
2012-09-13 |
2015-07-22 |
Ben-Gurion University Of The Negev Research And Development Authority |
Diagnosemittel mit erhöhter empfindlichkeit/spezifität
|
|
US9592407B2
(en)
|
2012-09-13 |
2017-03-14 |
Chang Gung Memorial Hospital |
Pharmaceutical composition and uses thereof
|
|
CN104661658A
(zh)
|
2012-09-26 |
2015-05-27 |
阿拉贡药品公司 |
用于治疗非转移性去势抵抗性前列腺癌的抗雄激素
|
|
EP2906260B1
(de)
|
2012-10-09 |
2019-06-26 |
Case Western Reserve University |
Stabförmige pflanzenvirusnanopartikel als kontrastmittelplattformen
|
|
EP2906207A4
(de)
|
2012-10-10 |
2016-10-26 |
Univ Arizona State |
Multifunktionelle radikale quencher
|
|
US20140120057A1
(en)
|
2012-10-25 |
2014-05-01 |
Rutgers, The State University Of New Jersey |
Polymers and methods thereof for wound healing
|
|
US9296730B2
(en)
|
2012-10-26 |
2016-03-29 |
Regents Of The University Of Minnesota |
Aurora kinase inhibitors
|
|
WO2014070774A1
(en)
|
2012-10-29 |
2014-05-08 |
Southern Methodist University |
Methods of generating beta-lactamase resistant carbapenem compounds
|
|
SG11201503620RA
(en)
|
2012-11-08 |
2015-06-29 |
Univ Rutgers |
Antimicrobial agents
|
|
US9701638B2
(en)
|
2012-11-09 |
2017-07-11 |
Rutgers, The State University Of New Jersey |
Therapeutic hydroxyquinolones
|
|
JP2016504284A
(ja)
|
2012-11-16 |
2016-02-12 |
バイオクリスト ファーマスーティカルズ，インコーポレイテッドＢｉｏｃｒｙｓｔ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． |
抗ウイルス性アザ糖を含有するヌクレオシド
|
|
WO2014078857A1
(en)
|
2012-11-19 |
2014-05-22 |
Regents Of The University Of Minnesota |
Ergoline derivatives as dopamine receptor modulators
|
|
ES2749467T3
(es)
|
2012-11-20 |
2020-03-20 |
Biogen Ma Inc |
Agentes moduladores de S1p y/o ATX
|
|
US9850206B2
(en)
|
2012-11-20 |
2017-12-26 |
Biogen Ma Inc. |
S1P and/or ATX modulating agents
|
|
US9522131B2
(en)
|
2013-01-11 |
2016-12-20 |
Wisconsin Alumni Research Foundation |
Tannin-containing gastrointestinal formulations and methods of use
|
|
JOP20200097A1
(ar)
|
2013-01-15 |
2017-06-16 |
Aragon Pharmaceuticals Inc |
معدل مستقبل أندروجين واستخداماته
|
|
US9765016B2
(en)
|
2013-01-29 |
2017-09-19 |
Biogen Ma Inc. |
S1P modulating agents
|
|
US9981043B2
(en)
|
2013-02-08 |
2018-05-29 |
Regents Of The University Of Minnesota |
Analgesic conjugates
|
|
KR20150119188A
(ko)
|
2013-02-15 |
2015-10-23 |
리젠츠 오브 더 유니버시티 오브 미네소타 |
입자 기능화
|
|
WO2014138302A1
(en)
|
2013-03-05 |
2014-09-12 |
University Of Notre Dame |
Quinazolinone antibiotics
|
|
BR112015022202A2
(pt)
|
2013-03-14 |
2017-07-18 |
Dart Neuroscience Cayman Ltd |
compostos substituídos de naftiridina e quinolina como inibidores da mao
|
|
CN108299400B
(zh)
|
2013-03-14 |
2021-02-19 |
达特神经科学(开曼)有限公司 |
作为pde4抑制剂的取代的吡啶和取代的吡嗪化合物
|
|
CA3160553A1
(en)
*
|
2013-03-15 |
2014-09-18 |
Rexahn Pharmaceuticals, Inc. |
Process for the preparation of 4-amino-1-((1s,4r,5s)-2-fluoro-4,5-dihydroxy-3-hydroxymethyl-cyclopent-2-enyl)-1h-pyrimidin-2-one
|
|
US9387250B2
(en)
|
2013-03-15 |
2016-07-12 |
Rutgers, The State University Of New Jersey |
Therapeutic compositions for bone repair
|
|
TW201446768A
(zh)
|
2013-03-15 |
2014-12-16 |
Biogen Idec Inc |
S1p及/或atx調節劑
|
|
US20160024504A1
(en)
|
2013-03-15 |
2016-01-28 |
Constellation Pharmaceuticals, Inc. |
Treating th2-mediated diseases by inhibition of bromodomains
|
|
US9617282B2
(en)
|
2013-03-15 |
2017-04-11 |
Biogen Ma Inc. |
Macrocyclic compounds as IRAK4 inhibitors for the treatment of inflammatory diseases
|
|
AU2014259672A1
(en)
|
2013-05-02 |
2015-12-03 |
The Regents Of The University Of California |
Bone-selective osteogenic oxysterol-bone targeting agents
|
|
KR102027663B1
(ko)
|
2013-05-06 |
2019-10-01 |
가오슝 창 궁 메모리얼 하스피털 |
약학적 조성물 및 이의 용도
|
|
US9862672B2
(en)
|
2013-05-29 |
2018-01-09 |
Rutgers, The State University Of New Jersey |
Antioxidant-based poly(anhydride-esters)
|
|
EP3010507A4
(de)
|
2013-06-22 |
2017-06-07 |
Nitor Therapeutics |
Zusammensetzungen und verfahren zur verstärkung der immunreaktion zur behandlung von infektionskrankheiten und krebs
|
|
US10682415B2
(en)
|
2013-07-22 |
2020-06-16 |
Wisconsin Alumni Research Foundation |
Thermogel formulation for combination drug delivery
|
|
US10117912B2
(en)
|
2013-08-01 |
2018-11-06 |
Regents Of The University Of Minnesota |
Drug delivery method
|
|
CN104341504B
(zh)
|
2013-08-06 |
2017-10-24 |
百奥泰生物科技(广州)有限公司 |
双特异性抗体
|
|
EP3030241A4
(de)
|
2013-08-06 |
2019-06-19 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Inhibitoren einer ack1/tnk2.tyrosinkinase
|
|
US10226534B2
(en)
|
2013-09-12 |
2019-03-12 |
Regents Of The University Of Minnesota |
Semi-solid delivery systems
|
|
US9878045B2
(en)
|
2013-10-15 |
2018-01-30 |
Regents Of The University Of Minnesota |
Triorthogonal reagents for dual protein conjugation
|
|
US10624943B2
(en)
|
2013-11-11 |
2020-04-21 |
Kuality Herbceutics, LLC |
Kava derived therapeutic compounds and methods of use thereof
|
|
US9387199B2
(en)
|
2013-11-12 |
2016-07-12 |
University Of Virginia Patent Foundation |
Compositions and methods for treating clostridium infection and preventing recurrence of infection
|
|
US9339482B2
(en)
|
2013-11-22 |
2016-05-17 |
Regents Of The University Of Minnesota |
Methods to treat dysregulated blood glucose disorders
|
|
US9315523B2
(en)
|
2013-12-06 |
2016-04-19 |
Rutgers, The State University Of New Jersey |
Cyclic dinucleosides
|
|
WO2015109318A2
(en)
|
2014-01-17 |
2015-07-23 |
Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University |
Therapeutic methods
|
|
US9919998B2
(en)
|
2014-02-06 |
2018-03-20 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: Nα-aroyl-N-aryl-phenylalaninamides
|
|
WO2015123654A1
(en)
|
2014-02-17 |
2015-08-20 |
The Cleveland Clinic Foundation |
Amine passivated nanoparticles for cancer treatment and imaging
|
|
ES2868882T3
(es)
|
2014-02-20 |
2021-10-22 |
Cornell Univ Cornell Center For Technology Enterprise & Commercialization Cctec |
Compuestos y métodos para inhibir fascina
|
|
US9908856B2
(en)
|
2014-02-26 |
2018-03-06 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Therapeutic compounds
|
|
US10189874B2
(en)
|
2014-02-26 |
2019-01-29 |
Arizona Board Of Regents On Behalf Of Arizona State University |
DNA gridiron compositions and methods
|
|
US10272055B2
(en)
|
2014-03-06 |
2019-04-30 |
Regents Of The University Of Minnesota |
Therapeutic compounds and methods
|
|
JP6574435B2
(ja)
|
2014-03-07 |
2019-09-11 |
バイオクリスト ファーマスーティカルズ，インコーポレイテッドＢｉｏｃｒｙｓｔ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． |
ヒト血漿カリクレイン阻害剤
|
|
US10197575B2
(en)
|
2014-03-31 |
2019-02-05 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Stabilized peptoid-peptide hybrids and uses thereof
|
|
CA2946112C
(en)
|
2014-04-18 |
2020-11-24 |
The Governors Of The University Of Alberta |
Targeted therapy to restore radioactive iodine transport in thyroid cancer
|
|
NZ725161A
(en)
|
2014-04-23 |
2017-10-27 |
Dart Neuroscience (Cayman) Ltd |
Substituted [1,2,4] triazolo [1,5-a] pyrimidin-7-yl compounds as pde2 inhibitors
|
|
MA39888A
(fr)
|
2014-04-24 |
2017-03-01 |
Dart Neuroscience Cayman Ltd |
Composés de 2,4,5,6-tétrahydropyrrolo[3,4-c] pyrazole et 4,5,6,7-tétrahydro-2 h-pyrazolo [4,3-c] pyridine utilisés comme inhibiteurs de glyt1
|
|
US9556113B2
(en)
|
2014-04-29 |
2017-01-31 |
The South Dakota Board Of Regents |
Combination uses of dichloroacetate and oxamate, and their prodrugs, for cancer treatment
|
|
US9987299B2
(en)
|
2014-05-05 |
2018-06-05 |
University Of Iowa Research Foundation |
Methods of improving RNAi in well-differentiated airway epithelia
|
|
US10144732B2
(en)
|
2014-06-06 |
2018-12-04 |
Biogen Ma Inc. |
ATX modulating agents
|
|
US10023521B2
(en)
|
2014-06-13 |
2018-07-17 |
Rutgers, The State University Of New Jersey |
Process and intermediates for preparing poly(anhydride-esters)
|
|
WO2015195563A1
(en)
|
2014-06-16 |
2015-12-23 |
Rutgers, The State University Of New Jersey |
Antibacterial agents
|
|
NL2013661B1
(en)
|
2014-10-21 |
2016-10-05 |
Ablynx Nv |
KV1.3 Binding immunoglobulins.
|
|
US9737598B2
(en)
|
2014-06-30 |
2017-08-22 |
Regents Of The University Of Minnesota |
CD200 inhibitors and methods of use thereof
|
|
EP3912635A1
(de)
|
2014-07-11 |
2021-11-24 |
Biostrategies LC |
Materialien und verfahren zur behandlung von leiden in zusammenhang mit sulfataseenzymen
|
|
WO2016011390A1
(en)
|
2014-07-18 |
2016-01-21 |
Biogen Ma Inc. |
Irak4 inhibiting agents
|
|
CN107148274A
(zh)
*
|
2014-08-19 |
2017-09-08 |
国立大学法人冈山大学 |
增强免疫细胞功能的方法和评估免疫细胞多功能性的方法
|
|
EP3265130A4
(de)
|
2014-08-19 |
2018-04-18 |
Hsiri Therapeutics, LLC |
Antibakterielle sideromycine
|
|
US10385034B2
(en)
|
2014-09-05 |
2019-08-20 |
The Cleveland Clinic Foundation |
Flavonoid IL-17A inhibitors
|
|
US9630905B2
(en)
|
2014-09-08 |
2017-04-25 |
Rutgers, The State University Of New Jersey |
Amphiphilic macromolecules and methods of use thereof
|
|
CA2964239C
(en)
|
2014-09-11 |
2022-12-13 |
University Of Iowa Research Foundation |
Thymol and carvacol for use in medicine
|
|
US10328114B2
(en)
|
2014-10-28 |
2019-06-25 |
University Of Iowa Research Foundation |
Lung injury repair compositions and methods
|
|
US10040759B2
(en)
|
2014-11-05 |
2018-08-07 |
Dart Neuroscience (Cayman) Ltd. |
Substituted azetidinyl compounds as GlyT1 inhibitors
|
|
EP3215508A1
(de)
|
2014-11-05 |
2017-09-13 |
Dart NeuroScience (Cayman) Ltd. |
Substituierte 5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-aminverbindungen als pde2-inhibitoren
|
|
US20190015379A1
(en)
*
|
2014-11-10 |
2019-01-17 |
Delmar Pharmaceuticals, Inc. |
Use of dianhydrogalactitol and analogs and derivatives thereof, together with radiation, to treat non-small-cell carcinoma of the lung and glioblastoma multiforme and suppress proliferation of cancer stem cells
|
|
US10920195B2
(en)
|
2014-11-13 |
2021-02-16 |
University Of Iowa Research Foundation |
Methods to generate epithelial cells
|
|
ES2811367T3
(es)
|
2014-11-17 |
2021-03-11 |
Cellectar Biosciences Inc |
Análogos de éteres fosfolipídicos como vehículos de fármacos que seleccionan como objetivo el cáncer
|
|
CA2971278C
(en)
|
2014-12-19 |
2023-09-19 |
Ablynx N.V. |
Cysteine linked nanobody dimers
|
|
US20180000736A1
(en)
|
2015-01-08 |
2018-01-04 |
University Of Iowa Research Foundation |
Methods for the regeneration of articular cartilage in vivo
|
|
US10669543B2
(en)
|
2015-01-16 |
2020-06-02 |
University Of Iowa Research Foundation |
Methods to prevent or treat periodontitis or peri-implantitis
|
|
WO2016133959A1
(en)
|
2015-02-17 |
2016-08-25 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Therapeutic compounds
|
|
AU2016220096B2
(en)
|
2015-02-17 |
2020-01-30 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Phenothiazine analogues as mitochondrial therapeutic agents
|
|
US10221143B2
(en)
|
2015-03-03 |
2019-03-05 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Substituted anilines for treatment of animal diseases
|
|
US10112917B2
(en)
|
2015-03-03 |
2018-10-30 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Therapeutic compounds
|
|
WO2016144871A1
(en)
|
2015-03-06 |
2016-09-15 |
The Cleveland Clinic Foundation |
Altering steroid metabolism for treatment of steroid-dependent disease
|
|
US9926261B2
(en)
|
2015-03-10 |
2018-03-27 |
Rutgers, The State University Of New Jersey |
Bacterial efflux pump inhibitors
|
|
US9950993B2
(en)
|
2015-03-13 |
2018-04-24 |
Rutgers, The State University Of New Jersey |
Bacterial efflux pump inhibitors
|
|
US10543162B2
(en)
|
2015-04-10 |
2020-01-28 |
Rutgers, The State University Of New Jersey |
Kojic acid polymers
|
|
WO2016179529A2
(en)
|
2015-05-06 |
2016-11-10 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Radiotherapeutic and companion imaging agents to target mc1r
|
|
WO2016179587A1
(en)
|
2015-05-07 |
2016-11-10 |
Kuality Herbceutics Llc |
Therapeutic compounds and methods of use thereof
|
|
US20180125780A1
(en)
|
2015-05-15 |
2018-05-10 |
The Methodist Hospital System |
Implantable nanochannel delivery devices
|
|
CA2986423C
(en)
|
2015-05-18 |
2022-05-10 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Enhanced melanoma cancer prevention by novel melanotropins
|
|
DK3302478T3
(da)
|
2015-06-05 |
2022-02-14 |
The Board Of Trustees Of The Univ Of Illionis |
Pac-1 kombinations behandling
|
|
TW201710503A
(zh)
|
2015-06-12 |
2017-03-16 |
長庚醫療財團法人林口長庚紀念醫院 |
新穎多核苷酸、載體、醫藥組成物以及其用途
|
|
US11369569B2
(en)
|
2015-06-15 |
2022-06-28 |
University Of Virginia Patent Foundation |
Target-specific delivery of therapeutic agents
|
|
US10308663B2
(en)
|
2015-06-16 |
2019-06-04 |
University Of Virginia Patent Foundation |
Inhibitors of PTP4A3 for the treatment of cancer
|
|
US9399039B1
(en)
|
2015-06-30 |
2016-07-26 |
University Of South Florida |
Inhibitors of the FKBP51 protein from a high-throughput drug screen and methods of use
|
|
WO2017011686A1
(en)
|
2015-07-14 |
2017-01-19 |
University Of Iowa Research Foundation |
Fluorescent prodrugs
|
|
WO2017011826A1
(en)
|
2015-07-16 |
2017-01-19 |
Case Western Reserve University |
Plant virus particles for delivery of antimitotic agents
|
|
AU2016298175B2
(en)
|
2015-07-28 |
2022-01-06 |
University Of Iowa Research Foundation |
Compositions and methods of treating cancer
|
|
CN108348779A
(zh)
|
2015-08-02 |
2018-07-31 |
H·李·莫菲特癌症中心研究有限公司 |
Ack1/tnk2酪氨酸激酶的抑制剂
|
|
WO2017027883A1
(en)
|
2015-08-13 |
2017-02-16 |
San Diego State University Research Foundation |
Atropisomerism for increased kinase inhibitor selectivity
|
|
DK3344626T5
(da)
|
2015-09-04 |
2021-09-06 |
Janssen Pharmaceutica Nv |
Terapeutiske forbindelser til smerte og syntese deraf
|
|
PT4019022T
(pt)
|
2015-10-01 |
2024-03-11 |
Biocryst Pharm Inc |
Inibidores da calicreína plasmática humana
|
|
WO2017066428A1
(en)
|
2015-10-13 |
2017-04-20 |
H. Lee Moffitt Cancer Center & Research Institute, Inc. |
Brd4-kinase inhibitors as cancer therapeutics
|
|
US20180296531A1
(en)
|
2015-10-20 |
2018-10-18 |
The Cleveland Clinic Foundation |
Stimulation of 11b-hsd2 expression to improve hormonal therapy of steroid-dependent disease
|
|
WO2017079335A1
(en)
|
2015-11-03 |
2017-05-11 |
Regents Of The University Of Minnesota |
Cd200 inhibitors and methods of use thereof
|
|
US10857156B2
(en)
|
2015-11-20 |
2020-12-08 |
Senhwa Biosciences, Inc. |
Combination therapy of tetracyclic quinolone analogs for treating cancer
|
|
US9957282B2
(en)
|
2015-12-14 |
2018-05-01 |
Senhwa Biosciences, Inc. |
Crystalline forms of quinolone analogs and their salts
|
|
US9980951B2
(en)
|
2015-12-17 |
2018-05-29 |
University Of Iowa Research Foundation |
Image guided therapy for cancer
|
|
TWI726969B
(zh)
|
2016-01-11 |
2021-05-11 |
比利時商健生藥品公司 |
用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
|
|
ES2904557T3
(es)
|
2016-01-20 |
2022-04-05 |
Biogen Ma Inc |
Agentes inhibidores de irak4
|
|
TWI747873B
(zh)
|
2016-02-01 |
2021-12-01 |
美商百歐克斯製藥公司 |
苯并吡唑化合物及其類似物
|
|
WO2017156527A1
(en)
|
2016-03-11 |
2017-09-14 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Aurora kinase and janus kinase inhibitors for prevention of graft versus host disease
|
|
US11395820B2
(en)
|
2016-03-16 |
2022-07-26 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Small molecules against cereblon to enhance effector t cell function
|
|
AU2017238208B2
(en)
|
2016-03-22 |
2022-01-06 |
Regents Of The University Of Minnesota |
Combination for treating pain
|
|
US10759740B2
(en)
|
2016-03-24 |
2020-09-01 |
Rutgers, The State University Of New Jersey |
Antibacterial agents
|
|
EP3442979A4
(de)
|
2016-04-04 |
2019-12-18 |
Rutgers, the State University of New Jersey |
Topoisomerasegifte
|
|
US10551384B2
(en)
|
2016-04-07 |
2020-02-04 |
Rutgers, The State University Of New Jersey |
MTOR kinase mutations and methods of use thereof
|
|
ES2946991T3
(es)
|
2016-04-18 |
2023-07-31 |
Gene Pool Tech Inc |
Aislamiento de extractos de plantas
|
|
CA3023225A1
(en)
|
2016-05-04 |
2017-11-09 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
A delta-opioid receptor targeted agent for molecular imaging and immunotherapy of cancer
|
|
US11697851B2
(en)
|
2016-05-24 |
2023-07-11 |
The Regents Of The University Of California |
Early ovarian cancer detection diagnostic test based on mRNA isoforms
|
|
CN109843378B
(zh)
|
2016-05-26 |
2022-06-10 |
匹兹堡大学联邦高等教育系统 |
用于治疗肺血管疾病的组合物和方法
|
|
US10899793B2
(en)
|
2016-05-27 |
2021-01-26 |
Regents Of The University Of Minnesota |
Melanocortin ligands and methods of use thereof
|
|
WO2017214296A1
(en)
|
2016-06-07 |
2017-12-14 |
University Of Iowa Research Foundation |
Junctophilin-2 fragments and uses therefor
|
|
US10851096B2
(en)
|
2016-06-20 |
2020-12-01 |
Rutgers, The State University Of New Jersey |
Aryl and heteroaryl amides for use as anti-proliferative, anti-thrombotic, and anti-viral agents
|
|
US11179484B2
(en)
|
2016-06-24 |
2021-11-23 |
University Of Iowa Research Foundation |
Compositions and methods of treating melanoma
|
|
US10918647B2
(en)
|
2016-07-26 |
2021-02-16 |
University Of Southern California |
Selective bromodomain inhibition of fungal Bdf1
|
|
US20180037909A1
(en)
|
2016-08-04 |
2018-02-08 |
Chang Gung Memorial Hospital, Linkou |
Modified cancer cell lines and uses thereof
|
|
WO2018039077A1
(en)
|
2016-08-25 |
2018-03-01 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Therapeutic compounds
|
|
MX2019002125A
(es)
|
2016-08-31 |
2019-06-20 |
Dart Neuroscience Llc |
Derivados de hidroxinorketamina para el tratamiento de trastornos.
|
|
MX2019004232A
(es)
|
2016-10-17 |
2019-08-01 |
Genentech Inc |
Compuestos terapéuticos y métodos para utilizarlos.
|
|
US11124541B2
(en)
|
2016-10-18 |
2021-09-21 |
Regents Of The University Of Minnesota |
Chimeric melanocortin ligands and methods of use thereof
|
|
MA46642A
(fr)
|
2016-10-31 |
2021-04-21 |
Biocryst Pharm Inc |
Promédicaments d'inhibiteurs de la kallicréine
|
|
US11071747B2
(en)
|
2016-11-29 |
2021-07-27 |
University Of Iowa Research Foundation |
Use of NAD precursors for breast enhancement
|
|
CN110234238B
(zh)
|
2016-11-29 |
2023-03-28 |
爱荷华大学研究基金会 |
Nad前体用于改善母体健康和/或后代健康的用途
|
|
US20180194824A1
(en)
|
2016-12-14 |
2018-07-12 |
University Of Iowa Research Foundation |
Musclin peptides and methods of use thereof
|
|
UY37551A
(es)
|
2016-12-27 |
2018-07-31 |
Biogen Ma Inc |
Activador de nrf2
|
|
AU2017388054B2
(en)
|
2016-12-28 |
2022-03-24 |
Dart Neuroscience, Llc |
Substituted pyrazolopyrimidinone compounds as PDE2 inhibitors
|
|
US10710957B2
(en)
|
2017-01-09 |
2020-07-14 |
University Of Central Florida Research Foundation, Inc. |
Motuporamine derivatives as antimicrobial agents and antibiotic enhancers against resistant gram-negative bacteria
|
|
US11261152B2
(en)
|
2017-01-20 |
2022-03-01 |
The Regents Of The University Of California |
Inhibitors of the N-terminal domain of the androgen receptor
|
|
US10238655B2
(en)
|
2017-01-23 |
2019-03-26 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Dihydroindene and tetrahydronaphthalene compounds
|
|
US10231947B2
(en)
|
2017-01-23 |
2019-03-19 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Isochroman compounds and methods of use thereof
|
|
US10238626B2
(en)
|
2017-01-23 |
2019-03-26 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Therapeutic compounds
|
|
EP3573957B1
(de)
|
2017-01-24 |
2023-04-26 |
Rivara, Mirko |
Zusammensetzungen und verfahren zur blockierung von natriumkanälen
|
|
US20190389836A1
(en)
|
2017-01-30 |
2019-12-26 |
Biogen Ma Inc. |
Nrf2 activator
|
|
WO2018140738A1
(en)
|
2017-01-30 |
2018-08-02 |
Biogen Ma Inc. |
Nrf 2 activator
|
|
US11168095B2
(en)
|
2017-02-07 |
2021-11-09 |
Biogen Ma Inc. |
ASK1 inhibiting agents
|
|
WO2018150276A2
(en)
|
2017-02-16 |
2018-08-23 |
Universidad San Sebastian |
The combination of cotinine plus antioxidant for treatment-resistant depression and correction of astrocytes functional deficit induced by depression and other neuropathological conditions
|
|
KR20190138790A
(ko)
|
2017-03-10 |
2019-12-16 |
루트거스, 더 스테이트 유니버시티 오브 뉴 저지 |
유출 펌프 억제제로서의 인돌 유도체
|
|
US11938114B2
(en)
|
2017-03-10 |
2024-03-26 |
Rutgers, The State University Of New Jersey |
Bacterial efflux pump inhibitors
|
|
WO2018165612A1
(en)
|
2017-03-10 |
2018-09-13 |
Rutgers, The State University Of New Jersey |
Bacterial efflux pump inhibitors
|
|
JOP20190233A1
(ar)
|
2017-04-14 |
2019-10-02 |
Biogen Ma Inc |
نظائر بنزوازيبين بوصفها عوامل مثبطة لتيروزين كيناز بروتون
|
|
US10294264B2
(en)
|
2017-04-21 |
2019-05-21 |
Warsaw Orthopedic, Inc. |
Oxysterol-therapeutic agent derivative for bone healing
|
|
CA3063174A1
(en)
|
2017-05-12 |
2018-11-15 |
Innovus Pharmaceuticals, Inc. |
Therapeutic methods and compositions
|
|
US10434106B2
(en)
|
2017-05-19 |
2019-10-08 |
Warsaw Orthopedic, Inc. |
Oxysterol-statin compounds for bone growth
|
|
WO2018217757A1
(en)
|
2017-05-22 |
2018-11-29 |
University Of Virginia Patent Foundation |
Compositions and methods for preparing and using mitochondrial uncouplers
|
|
WO2018218192A1
(en)
|
2017-05-26 |
2018-11-29 |
Rutgers, The State University Of New Jersey |
Bacterial efflux pump inhibitors
|
|
BR112019024333A2
(pt)
|
2017-06-02 |
2020-07-28 |
Merck Patent Gmbh |
imunoglobulinas de ligação adamts
|
|
AU2018278275A1
(en)
|
2017-06-02 |
2019-12-19 |
Ablynx N.V. |
MMP13 binding immunoglobulins
|
|
MX2019014397A
(es)
|
2017-06-02 |
2020-02-10 |
Merck Patent Gmbh |
Polipeptidos que enlazan adamts5, mmp13 y agrecano.
|
|
WO2018220225A1
(en)
|
2017-06-02 |
2018-12-06 |
Ablynx Nv |
Aggrecan binding immunoglobulins
|
|
AR112027A1
(es)
|
2017-06-15 |
2019-09-11 |
Biocryst Pharm Inc |
Inhibidores de alk 2 quinasa que contienen imidazol
|
|
WO2018237241A1
(en)
|
2017-06-22 |
2018-12-27 |
University Of Virginia Patent Foundation |
ATOMIC MEDICINE ACTIVATED BY PROTONS
|
|
EP3641776B1
(de)
|
2017-06-23 |
2023-10-18 |
San Diego State University Research Foundation |
Atropisomerismus für erhöhte kinasehemmerselektivität
|
|
WO2019005841A1
(en)
|
2017-06-26 |
2019-01-03 |
Rutgers, The State University Of New Jersey |
THERAPEUTIC COMPOUNDS AND METHODS FOR TREATING INFECTION
|
|
MX2020000295A
(es)
|
2017-07-12 |
2020-07-22 |
Dart Neuroscience Llc |
Compuestos de benzoxazol y benzofurano sustituidos como inhibidores de pde7.
|
|
CN107446050A
(zh)
|
2017-08-11 |
2017-12-08 |
百奥泰生物科技(广州)有限公司 |
Trop2阳性疾病治疗的化合物及方法
|
|
US11186549B2
(en)
|
2017-08-29 |
2021-11-30 |
Rutgers, The State University Of New Jersey |
Therapeutic indazoles
|
|
US11254941B2
(en)
|
2017-08-30 |
2022-02-22 |
Arizona Board Of Regents On Behalf Of Arizona State University |
RNA nanostructures and methods of making and using RNA nanostructures
|
|
EP3691644A4
(de)
|
2017-10-06 |
2021-06-30 |
Blue Therapeutics, Inc. |
Verfahren zur behandlung von akuten oder chronischen schmerzen
|
|
CN111479560A
(zh)
|
2017-10-16 |
2020-07-31 |
阿拉贡药品公司 |
用于治疗非转移性去势难治性前列腺癌的抗雄激素
|
|
CA3116829A1
(en)
|
2017-10-17 |
2019-04-25 |
The Methodist Hospital System |
Delivery devices
|
|
WO2019104030A1
(en)
|
2017-11-21 |
2019-05-31 |
Biogen Ma Inc. |
Tetrahydronaphthalene derivatives useful as nrf2 activators
|
|
CA3120971A1
(en)
|
2017-11-27 |
2019-05-31 |
Dart Neuroscience, Llc |
Substituted furanopyrimidine compounds as pde1 inhibitors
|
|
EP3716956A1
(de)
|
2017-11-29 |
2020-10-07 |
The Cleveland Clinic Foundation |
Antitumor-tet2-modulierende verbindungen
|
|
CN111683654A
(zh)
|
2017-11-30 |
2020-09-18 |
细胞凝胶制药有限责任公司 |
新型镇痛药物制剂及其用途
|
|
WO2019112885A1
(en)
|
2017-12-07 |
2019-06-13 |
The Cleveland Clinic Foundation |
Treatment of steroid-resistant disease using an anthocyanin and a corticosteroid
|
|
WO2019140140A1
(en)
|
2018-01-10 |
2019-07-18 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Rna-nanostructured double robots and methods of use thereof
|
|
US10738093B2
(en)
|
2018-01-25 |
2020-08-11 |
The Hong Kong University Of Science And Technology |
Discovery of cationic nonribosomal peptides as Gram-negative antibiotics through global genome mining
|
|
EP3752143A4
(de)
|
2018-02-13 |
2021-08-11 |
Rutgers, The State University of New Jersey |
Antibakterielle mittel: o-alkyl-deuterierte pyronine
|
|
JP7445597B2
(ja)
|
2018-02-15 |
2024-03-07 |
センワ バイオサイエンシズ インコーポレイテッド |
キノロン類似体及びそれらの塩、組成物、ならびにそれらの使用方法
|
|
US11890352B2
(en)
|
2018-02-27 |
2024-02-06 |
University Of Virginia Patent Foundation |
Plectin-targeted liposomes/PARP inhibitor in the treatment of cancer
|
|
JP7386797B2
(ja)
|
2018-02-28 |
2023-11-27 |
ダート・ニューロサイエンス・エルエルシー |
Ｎｏｐ阻害剤としての置換シクロヘキシル化合物
|
|
US11572337B2
(en)
|
2018-03-06 |
2023-02-07 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: arylalkylcarboxamido phloroglucinols
|
|
WO2019178267A2
(en)
|
2018-03-13 |
2019-09-19 |
University Of Iowa Research Foundation |
Inductive regeneration of the airway by transcriptional factor modulation of glandular myoepithelial stem cells
|
|
WO2019178191A1
(en)
|
2018-03-14 |
2019-09-19 |
Biogen Ma Inc. |
O-glycoprotein-2-acetamido-2-deoxy-3-d-glycopyranosidase inhibitors
|
|
TW202010742A
(zh)
|
2018-04-06 |
2020-03-16 |
美商百歐克斯製藥公司 |
取代的苯并呋喃、苯并吡咯、苯并噻吩及結構相關的補體抑制劑
|
|
JP2021523934A
(ja)
|
2018-04-20 |
2021-09-09 |
バージニア・テック・インテレクチュアル・プロパティーズ・インコーポレイテッドＶｉｒｇｉｎｉａ Ｔｅｃｈ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｉｅｓ， Ｉｎｃ． |
ミトコンドリア脱共役剤として有用なアミノピラジンおよび関連化合物
|
|
US20210230601A1
(en)
|
2018-04-27 |
2021-07-29 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Highly knotted molecular topologies from single-stranded nucleic acids
|
|
TW202016097A
(zh)
|
2018-05-14 |
2020-05-01 |
美商百健Ｍａ公司 |
布魯頓氏酪胺酸激酶之抑制劑
|
|
SG11202012784SA
(en)
|
2018-06-27 |
2021-01-28 |
Biogen Ma Inc |
Ask1 inhibiting agents
|
|
CA3105743A1
(en)
|
2018-07-09 |
2020-01-16 |
Taiwan Liposome Co., Ltd. |
Methods to reduce complications of intra-articular steroid
|
|
AU2019301679A1
(en)
|
2018-07-11 |
2021-01-28 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Dimeric immuno-modulatory compounds against cereblon-based mechanisms
|
|
US10898460B1
(en)
|
2018-07-20 |
2021-01-26 |
University Of South Florida |
Leishmania inhibitors
|
|
ES2945183T3
(es)
|
2018-08-14 |
2023-06-29 |
Biogen Ma Inc |
Compuestos macrocíclicos de piridina como agentes inhibidores de ASK1
|
|
EP3837251B1
(de)
|
2018-08-14 |
2023-06-21 |
Biogen MA Inc. |
Ask1-hemmende mittel
|
|
US11332499B2
(en)
|
2018-08-16 |
2022-05-17 |
Regents Of The University Of Minnesota |
Cyclic peptides and methods of use thereof
|
|
US20200085784A1
(en)
|
2018-09-13 |
2020-03-19 |
Minneamrita Therapeutics, LLC |
Methods to treat fibrosis, nash, and nafld
|
|
PE20211591A1
(es)
|
2018-09-19 |
2021-08-18 |
Biogen Ma Inc |
Inhibidores de o-glicoproteina-2-acetamido-2-desoxi-3-d-glucopiranosidasa
|
|
EP3866926A1
(de)
|
2018-10-15 |
2021-08-25 |
Biogen MA Inc. |
Kristalline polymorphe von bruton-tyrosinkinasehemmern
|
|
EP3866834A1
(de)
|
2018-10-17 |
2021-08-25 |
Sunstate Biosciences, LLC |
Einzelproteinverkapselte arzneimittel zur verstärkung therapeutischer wirkungen
|
|
WO2020097433A1
(en)
|
2018-11-09 |
2020-05-14 |
The University Of Rochester |
Methods and systems for treating cancer based on response prediction using light scattering technology
|
|
US20230132366A9
(en)
|
2018-11-26 |
2023-04-27 |
Denali Therapeutics Inc. |
Methods for treating dysregulated lipid metabolism
|
|
JP2022510430A
(ja)
|
2018-12-05 |
2022-01-26 |
バイオジェン・エムエイ・インコーポレイテッド |
モルホリニル、ピペラジニル、オキサゼパニル及びジアゼパニルｏ－糖タンパク質－２－アセトアミド－２－デオキシ－３－ｄ－グルコピラノシダーゼ阻害剤
|
|
JP2022517226A
(ja)
|
2019-01-14 |
2022-03-07 |
リージェンツ オブ ザ ユニバーシティ オブ ミネソタ |
がん免疫療法のためのｃｄ２００ａｒリガンド
|
|
EP3921316A1
(de)
|
2019-02-04 |
2021-12-15 |
Biogen MA Inc. |
Bicyclische ether-o-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase-inhibitoren
|
|
MA55203A
(fr)
|
2019-03-08 |
2022-01-12 |
Biogen Ma Inc |
Inhibiteurs d'azétidinyl 0-glyc0pr0téin-2-acétamid0-2-désoxy-3-d-gluc0pyran0sidase
|
|
WO2020225779A1
(en)
|
2019-05-09 |
2020-11-12 |
Istituto Pasteur Italia - Fondazione Cenci Bolognetti |
Rig-i agonists for cancer treatment and immunotherapy
|
|
WO2020232330A1
(en)
|
2019-05-15 |
2020-11-19 |
Biogen Ma Inc. |
Inhibiting agents for bruton's tyrosine kinase
|
|
US20220241214A1
(en)
|
2019-06-20 |
2022-08-04 |
University Of Iowa Research Foundation |
Nanoparticles comprising quinone w methides and compositions for use
|
|
US20220411398A1
(en)
|
2019-06-24 |
2022-12-29 |
University Of Iowa Research Foundation |
Jnk inhibitors as anticancer agents
|
|
MX2022001608A
(es)
|
2019-08-06 |
2022-03-11 |
Biocryst Pharm Inc |
Sintesis de un inhibidor de calicreina plasmatica a escala de proceso.
|
|
US20220372040A1
(en)
|
2019-10-25 |
2022-11-24 |
Accent Therapeutics, Inc. |
Mettl3 modulators
|
|
WO2021086966A1
(en)
|
2019-10-29 |
2021-05-06 |
Biogen Ma Inc. |
Spirocyclic o-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors
|
|
JP2023501236A
(ja)
|
2019-10-30 |
2023-01-18 |
バイオジェン・エムエイ・インコーポレイテッド |
ブルトン型チロシンキナーゼに対する阻害剤としての縮合型二複素環
|
|
JP2023501238A
(ja)
|
2019-10-30 |
2023-01-18 |
バイオジェン・エムエイ・インコーポレイテッド |
Ｂｔｋ阻害剤としての縮合ピリダジンまたはピリミジン
|
|
JP2023508394A
(ja)
|
2019-12-23 |
2023-03-02 |
バイオジェン・エムエイ・インコーポレイテッド |
Ｂｔｋ阻害剤
|
|
WO2021142230A1
(en)
|
2020-01-10 |
2021-07-15 |
Cornell University |
Methods to alter latency in ebv+ malignancies
|
|
WO2021236578A1
(en)
|
2020-05-18 |
2021-11-25 |
Salk Institute For Biological Studies |
Chromen-4-one derivatives, such as e.g. flavones, for use as ck2 inhibitors for the treatment of neuroinflammation
|
|
TWI776584B
(zh)
|
2020-07-10 |
2022-09-01 |
長庚醫療財團法人林口長庚紀念醫院 |
β-1腎上腺素受體拮抗劑用於製備減少表皮生長因子受體抑制劑誘導的上皮細胞損傷以及抑制癌細胞的組合物之用途
|
|
US11529335B2
(en)
|
2020-07-31 |
2022-12-20 |
University Of Iowa Research Foundation |
Compositions and methods for treating cancer
|
|
UY39370A
(es)
|
2020-08-07 |
2022-02-25 |
Biogen Ma Inc |
Inhibidores de la btk
|
|
AU2021336300A1
(en)
|
2020-09-02 |
2023-03-16 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
LZK-targeting degraders and methods of use
|
|
US20240051985A1
(en)
|
2020-10-14 |
2024-02-15 |
Accent Therapeutics, Inc. |
Mettl3 modulators
|
|
EP4274832A1
(de)
|
2021-01-07 |
2023-11-15 |
Biogen MA Inc. |
Tyk2-inhibitoren
|
|
KR20230148180A
(ko)
|
2021-02-22 |
2023-10-24 |
리전츠 오브 더 유니버스티 오브 미네소타 |
면역조절제 및 면역조절제 컨쥬게이트
|
|
TWI796023B
(zh)
|
2021-03-10 |
2023-03-11 |
長庚醫療財團法人 |
藥物組合物及其用途
|
|
WO2022212893A1
(en)
|
2021-04-02 |
2022-10-06 |
Biogen Ma Inc. |
Combination treatment methods of multiple sclerosis
|
|
US11780828B2
(en)
|
2021-05-04 |
2023-10-10 |
Regents Of The University Of Minnesota |
Contraceptive compounds and methods
|
|
BR112023023065A2
(pt)
|
2021-05-05 |
2024-01-30 |
Biogen Ma Inc |
Compostos para direcionar a degradação da tirosina quinase de bruton
|
|
AU2022297453A1
(en)
|
2021-06-22 |
2024-01-04 |
Crimson Biopharm Inc. |
(1h-pyrrolo[2,3-b]pyridin-1-yl)pyrimidin-2-yl-amino-phenyl--acrylamide inhibitors of egfr for use in the treatment of brain tumors
|
|
WO2022271951A1
(en)
|
2021-06-23 |
2022-12-29 |
University Of Iowa Research Foundation |
Sustained release formulations comprising a selective androgen receptor modulator
|
|
WO2023283372A1
(en)
|
2021-07-07 |
2023-01-12 |
Biogen Ma Inc. |
Compounds for targeting degradation of irak4 proteins
|
|
CA3224732A1
(en)
|
2021-07-07 |
2023-01-12 |
Kevin M. Guckian |
Compounds for targeting degradation of irak4 proteins
|
|
CA3229861A1
(en)
|
2021-09-01 |
2023-03-09 |
John F. BROGNARD |
Mixed lineage kinase inhibitors and methods of use
|
|
WO2023081237A1
(en)
|
2021-11-03 |
2023-05-11 |
Regents Of The University Of Minnesota |
Toll-like receptor agonists and antagonists and uses thereof
|
|
WO2023086521A1
(en)
|
2021-11-10 |
2023-05-19 |
Biogen Ma Inc. |
Btk inhibitors
|
|
WO2023086575A1
(en)
|
2021-11-12 |
2023-05-19 |
Biogen Ma Inc. |
Btk inhibitors
|
|
WO2023092060A1
(en)
|
2021-11-18 |
2023-05-25 |
Cornell University |
Microrna-dependent mrna switches for tissue-specific mrna-based therapies
|
|
WO2023130022A2
(en)
|
2021-12-29 |
2023-07-06 |
University Of Iowa Research Foundation |
Cystatin rna compositions for tissue engineering
|
|
WO2023220046A1
(en)
|
2022-05-10 |
2023-11-16 |
Biogen Ma Inc. |
Tyk2 inhibitors
|
|
WO2023220049A1
(en)
|
2022-05-10 |
2023-11-16 |
Biogen Ma Inc. |
Crystalline polymorphs of n-methyl-n-((1s,3s)-3-methyl-3-((6-(1-methyl-1h-pyrazol-4-yl)pyrazolo[1,5-a]pyrazin-4-yl)oxy)cyclobutyl)acrylamide
|
|
WO2024006977A1
(en)
|
2022-07-01 |
2024-01-04 |
University Of Southern California |
Analgesic delta opioid receptor bitopic ligands
|
|
WO2024006493A1
(en)
|
2022-07-01 |
2024-01-04 |
Biogen Ma Inc. |
Tyk2 inhibitors
|
|
WO2024009283A1
(en)
|
2022-07-07 |
2024-01-11 |
University Of Southern California |
At2 antagonists for non-addictive pain relief
|
|
WO2024011214A1
(en)
|
2022-07-08 |
2024-01-11 |
Actio Biosciences, Inc. |
Therapeutic compounds and methods
|